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ABSTRACT 
In this work, I have developed optimization-based algorithms to reconstruct and 
analyze metabolic network models, and I have applied them to the metabolism of the 
filamentous fungus Neurospora crassa.  The developed algorithms are: (1) LInear 
MEtabolite Dilution Flux Balance Analysis (limed-FBA), which predicts flux while 
linearly accounting for metabolite dilution; (2) One-step functional Pruning (OnePrune), 
which removes blocked reactions with a single compact linear program; and (3) 
Consistent Reproduction Of growth/no-growth Phenotype (CROP), which reconciles 
differences between in silico and experimental gene essentiality faster than previous 
approaches.  Together, these algorithms comprise Fast Automated Reconstruction of 
Metabolism (FARM).  FARM was applied to reconstruct the first genome-scale model of 
N. crassa metabolism.  This organism has played a central role in the development of 
twentieth-century genetics, biochemistry and molecular biology, and continues to serve 
as a model organism for eukaryotic biology.  The N. crassa model consists of 836 
metabolic genes, 257 pathways, 6 cellular compartments, and is supported by extensive 
iv 
manual curation of 491 literature citations.  Against an independent test set of more than 
300 essential/non-essential genes that were not used to train the model, it displays 93% 
sensitivity and specificity.  The model was also used to simulate the biochemical genetics 
experiments originally performed on N. crassa by comprehensively predicting nutrient 
rescue of essential genes and synthetic lethal interactions, and providing detailed 
pathway-based mechanistic explanations of the predictions.  The model provides a 
reliable computational framework for the integration and interpretation of ongoing 
experimental efforts in N. crassa, and the algorithms will enhance reconstruction and 
analysis of high-quality genome-scale metabolic models in general. 
  
v 
Preface 
The vast majority of this thesis is based on our manuscript: Dreyfuss JM, Zucker 
JD, Hood HM, Ocasio LR, Sachs MS, Galagan JE (2013) Reconstruction and Validation 
of a Genome-Scale Metabolic Model for the Filamentous Fungus Neurospora 
crassa Using FARM. PLoS Comput Biol 9(7): e1003126. The supporting tables, Table 
S1 and Table S2, are too large to include here, but can be found online associated with 
our manuscript. The supporting figures are included here, in the appendix. 
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1 Introduction 
In this thesis, I develop algorithms for reconstruction and analysis of 
stoichiometric metabolic models, and I apply these algorithms to construct the first 
genome-scale stoichiometric metabolic model for the filamentous fungus Neurospora 
crassa. In this first introductory chapter, I provide a brief overview of the topic, to allow 
the reader to understand the subsequent sections. Further introductory material is 
provided at the beginning of each chapter. 
1.1 Neurospora 
Fungi are one of the kingdoms of eukaryotes. Of the many species of fungi, ~ 
75% are Ascomycetes and ~25% are Basidiomycetes; of the Ascomycetes, ~10% are 
yeasts and the remainder are filamentous fungi (Dunlap, Borkovich et al. 2007). Thus, 
most of the fungal species are filamentous fungi. 
Knowledge of filamentous fungi is highly valuable. Fungi are more closely 
related to animals than plants, yet they’re much more experimentally tractable than 
animals, so they serve as valuable model organisms for our own biological processes. 
Some filamentous fungi are important, difficult-to-treat plant and animal pathogens. 
Filamentous fungi are also used industrially to produce high volumes of enzymes and 
chemicals (Dunlap, Borkovich et al. 2007; Andersen, Nielsen et al. 2008). 
As a model organism for filamentous fungi, Neurospora crassa has a rich history 
of experimental study. First discovered as an orange mold infestation of Paris bakeries in 
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1843 (Davis 2000), the filamentous fungus Neurospora crassa has become a model 
organism for eukaryotic biology and the cornerstone of a vibrant research community 
(Perkins 1992). Work on Neurospora has led to essential discoveries in circadian rhythms 
(Baker, Loros et al. 2012), epigenetics (Rountree and Selker 2010), genome defense 
(Selker, Cambareri et al. 1987), mitochondrial biology (Nargang and Rapaport 2007), 
post-transcriptional gene silencing (Romano and Macino 1992) and DNA repair (Inoue 
2011). Most famously, work in the 1940’s by Beadle and Tatum led to the Nobel Prize-
winning 'one-gene-one-enzyme' hypothesis that established the fundamental link between 
genes and proteins in all organisms (Beadle and Tatum 1941; Tatum and Beadle 1942). 
Work on Neurospora thus paved the way for modern genetics and molecular biology. 
Of equal consequence, the work by Beadle and Tatum ushered in a new era in the 
study of biochemistry and cellular metabolism. The genetic facility of Neurospora, 
coupled with its ability to grow on minimal media, simplified the isolation of mutants 
with additional nutrient requirements. The first such auxotrophic mutants established the 
universal link among genes, enzymes, and the ordering of reactions in biosynthetic 
pathways. Work over subsequent decades led to a compilation of hundreds of such 
mutants, shedding light on most major biosynthetic pathways (Perkins, Radford et al. 
2001; Radford 2004; McCluskey, Wiest et al. 2010). With the sequencing and annotation 
of the Neurospora genome (Galagan, Calvo et al. 2003; Borkovich, Alex et al. 2004), 
these genetic data could be organized on a physical scaffold, genetic markers could be 
assigned to specific genes with predicted biochemical functions, genes could be assigned 
to previously orphaned biochemical reactions, and a global map of Neurospora 
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metabolism could begin to emerge. 
Substantial work on this metabolic map was summarized in 2004 (Radford 2004), 
in terms of individual pathways. However, these pathways were not woven together to 
form a genome-scale metabolic model. In this thesis, we corrected the available map and 
expanded upon it using the available literature and computational analyses to create a 
genome-scale model. 
1.2 Stoichiometric metabolic models 
One powerful approach for studying the underlying cellular processes that give 
rise to the relationship between genotype and phenotype is through in silico modeling. In 
these models, each gene is associated with zero or more enzymes. Enzymes are 
assembled into biochemical pathways, which make it possible to visualize what nutrients 
the organism can eat and what metabolites it can produce. Pathways are combined into a 
metabolic network in order to predict whether the organism can produce all essential 
biomass compounds necessary for growth in a given nutrient media. To explain why a 
gene is essential for growth, we can remove the enzyme coded by that gene from the 
network to see whether all essential biomass compounds can still be produced. To 
generate an in silico model that has this level of predictive power, we could have 
attempted to build a fully-parameterized kinetic model, but there are currently few kinetic 
parameters in Neurospora whose in vivo value is known (Teusink, Passarge et al. 2000; 
Selinger, Wright et al. 2003). 
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As an alternative to kinetic models, we chose to focus on models that rely only on 
reaction stoichiometry. These stoichiometric models make the simplifying assumption 
that on an appropriate time-scale, internal metabolite concentrations do not grow or 
shrink. Therefore, the steady-state flow of metabolites through the network can be easily 
computed. Furthermore, by incorporating knowledge of the biomass composition, 
nutrient uptake rates, and thermodynamic constraints on reaction reversibility, we can use 
a method called flux balance analysis (FBA) to predict the effect of a gene knockout on 
growth. 
FBA represents a metabolic network by capturing the stoichiometries of 
constituent reactions in a stoichiometric matrix, S. The matrix S and the set of reaction 
constraints for lower bounds (lb) and upper bounds (ub) define the set of all possible flux 
configurations v at steady state. By defining a metabolic objective function c that 
represents all the essential biomass components necessary for growth, linear 
programming can be used to check whether the model supports growth under a given 
nutrient condition. The linear programming problem is: 
 
where the 1st line represents the objective and the lines below represent constraints. FBA 
can be used to predict gene essentiality by blocking reactions that correspond to the gene 
knockout and checking if the model can still support growth (Chang, Ghamsari et al. 
2011; Lewis, Nagarajan et al. 2012).  
max
 0
T
v
lb ub
c v
Sv
v≤ ≤
=
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 Using constraint-based modeling methods like FBA (Lewis, Nagarajan et al. 
2012), it is possible to predict the growth rate of organisms under different conditions 
(Varma and Palsson 1994), the rate of production of metabolites of interest (Plata, Hsiao 
et al. 2010), the phenotypic consequences of gene knockouts, and the metabolic impact of 
different gene expression programs (Colijn, Brandes et al. 2009; Brandes, Lun et al. 
2012). Constraint-based methods are also being used to guide metabolic engineering 
efforts by calculating the modifications required to optimize the production of desired 
metabolites (Burgard, Pharkya et al. 2003; Pharkya, Burgard et al. 2004; Patil, Rocha et 
al. 2005; Lun, Rockwell et al. 2009). 
1.3 Metabolic reconstructions 
Genome-scale metabolic models have been constructed for over 100 organisms 
spanning bacteria to mammalian cells (Feist, Herrgard et al. 2009), but a number of 
significant challenges remain in the reconstruction of high-quality genome-scale 
metabolic models (Thiele and Palsson 2010). Although bioinformatic methods exist that 
can automate the generation of draft metabolic models (Henry, DeJongh et al. 2010), 
extensive manual adjustment and literature curation remains essential for generating 
high-quality models. The assessment of model accuracy through independent empirical 
validation is also critical if the predictions of the model are to be trusted. Although a 
number of methods have been developed to aid in this task (Reed, Patel et al. 2006; 
Kumar, Dasika et al. 2007; Elloumi, Küng et al. 2008; Christian, May et al. 2009; Henry, 
Zinner et al. 2009; Kumar and Maranas 2009; Jerby, Shlomi et al. 2010; Zomorrodi and 
Maranas 2010; Agren, Bordel et al. 2012; Latendresse, Krummenacker et al. 2012; 
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Mintz-Oron, Meir et al. 2012; Vitkin and Shlomi 2012), substantial manual effort is also 
still required. 
To facilitate the automation of metabolic network reconstruction, we developed 
three optimization-based algorithms, which together comprise Fast Automated 
Reconstruction of Metabolism (FARM). These algorithms are: LInear MEtabolite 
Dilution Flux Balance Analysis (limed-FBA), which predicts flux while linearly 
accounting for metabolite dilution; Consistent Reproduction Of growth/no-growth 
Phenotype (CROP), which reconciles differences between in silico and experimental 
gene essentiality faster and more accurately than previous approaches and in a more 
disciplined manner; and One-step functional Pruning (OnePrune), which removes 
blocked reactions with a single compact linear program.  
FARM can be used in the future instead of previously available algorithms. For 
example, CROP can be used instead of the Model SEED (Henry, Zinner et al. 2009; 
Henry, DeJongh et al. 2010) and GrowMatch (Kumar and Maranas 2009; Zomorrodi and 
Maranas 2010) to achieve better consistency between in silico and experimental gene 
essentiality and more disciplined estimation of reaction presence based on biochemical 
and thermodynamic data. 
1.4 Our modeling process 
The wealth of genetic and metabolic data available for Neurospora, along with 
ongoing efforts to knock-out and phenotypically characterize all ~10,000 genes in the 
genome (Dunlap, Borkovich et al. 2007), provides a strong foundation for the 
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development of a genome-scale metabolic model for Neurospora. A metabolic model 
would, in turn, complement experimental efforts by integrating data from experiments on 
single genes into a coherent genome-wide metabolic framework, providing potential 
mechanistic insight into experimental phenotypic observations, and enabling the 
comprehensive modeling of perturbations that could not be feasibly performed in the lab. 
A genome-scale model is also a requirement for the rational and efficient use of 
Neurospora as a potential biofuels organism (Rao, Deshpande et al. 1983; Deshpande, 
Keskar et al. 1986; Zhang, Qu et al. 2008; Tian, Beeson et al. 2009; Znameroski, 
Coradetti et al. 2012). 
To construct the model, we reconstructed, validated and performed computational 
predictions with the Neurospora metabolic network model in a process consisting of four 
stages, as shown in Figure 1. Below we summarize the steps of the process, then we 
describe the optimization-based algorithms we developed to guide the process. 
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Figure 1. Modeling process. The process used for the reconstruction and validation of the metabolic model is 
described in four stages. In the first stage, pathway-directed curation, the genome sequence annotation 
(Galagan, Calvo et al. 2003; Borkovich, Alex et al. 2004) , metabolic pathways derived from MetaCyc 
(Karp, Paley et al. 2002; Caspi, Altman et al. 2012) and experimental evidence from the Neurospora 
bibliome (Karp, Paley et al. 2004) were used to construct the first draft of the NeurosporaCyc 
Pathway/Genome database (Karp, Ouzounis et al. 2005). For the second stage, iterative phenotype-directed 
curation, we utilized FARM to suggest changes to the metabolic network based on a training set of 
experimentally observed growth phenotypes. These suggestions were reviewed manually, and accepted into 
the final model only if they were consistent with published experimental evidence. In the third stage, we 
independently validated the model based on a test set of experimentally observed viability phenotypes that 
were not utilized during model construction. In the fourth stage, we comprehensively predicted the 
phenotypes of all essential genes, nutrient rescues, and synthetic lethal interactions.  
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1.4.1 Stage 1: Pathway-directed curation 
We integrated the Neurospora genome and literature to generate an initial draft of 
the metabolic network. This process was initiated by computing the probability that each 
enzyme activity is encoded in the genome sequence (Galagan, Calvo et al. 2003) using 
the EFICAz enzyme function predictor (Arakaki, Huang et al. 2009). These predicted 
enzyme activities were then automatically assembled into experimentally elucidated 
pathways taken from MetaCyc (Caspi, Altman et al. 2012) using the Pathologic pathway 
prediction algorithm (Dale, Popescu et al. 2010). Complementing this automated 
approach, we manually curated Neurospora-specific literature to identify experimentally 
determined enzymes, assign Gene Ontology terms to proteins, distinguish isozymes from 
enzyme complexes, catalog growth observations, and estimate the biomass composition 
(Ashburner, Ball et al. 2000; Borkovich, Alex et al. 2004; Dunlap, Borkovich et al. 
2007). Each assertion in the database was labeled with an evidence code to specify the 
type of experiment or computation performed to support its inclusion in the metabolic 
network (Karp, Paley et al. 2004). 
1.4.2 Stage 2: Phenotype-directed curation 
We iteratively improved the initial metabolic model with a manually curated 
training set of experimentally observed viability phenotypes on minimal and 
supplemented media. We used FARM on this set to suggest reaction additions/removals 
that would improve prediction accuracy. These changes were manually reviewed and 
accepted only if consistent with published experimental evidence.  
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1.4.3 Stage 3: Independent validation of model predictions 
To confirm that the final model was not over-fit to a single training set and to 
ensure that the predictions of the model could generalize to new phenotypes, we validated 
the model using an independent test set of experimentally observed viability phenotypes. 
1.4.4 Stage 4: Comprehensive viability phenotype prediction 
We applied the final model to generate three sets of predictions. Firstly, we 
predicted the essentiality of all genes in our model. Secondly, we predicted which 
nutrient supplements would rescue a manually curated set of inviable mutants, and 
provided mechanistic explanations for each rescue. Thirdly, we systematically performed 
in silico double knockout experiments to predict synthetic lethal interactions. In all three 
cases, published observations were available that validated the accuracy of the 
predictions. The metabolic model extends these published observations in a manner that 
would be difficult experimentally by assaying a comprehensive set of conditions, 
providing novel testable hypotheses, and providing potential mechanistic insight into 
these predictions. 
2 Linear Metabolite Dilution Flux Balance Analysis (limed-FBA) 
2.1 Background 
Flux balance analysis is a widely used method for predicting metabolic capabilities 
using genome-scale metabolic network models (Orth, Thiele et al. 2010). FBA represents 
a metabolic network by capturing the stoichiometries of constituent reactions in a 
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stoichiometric matrix, S. The matrix S and the set of reaction constraints lb and ub define 
the set of all possible flux configurations v at steady state. By defining a metabolic 
objective function cTv that represents all the essential biomass components necessary for 
growth, linear programming can be used to predict whether the model supports growth 
under a given nutrient condition. The linear programming problem is: 
 
FBA can be used to predict gene essentiality by blocking reactions that correspond to the 
gene knockout and checking if the model can still support growth (Chang, Ghamsari et al. 
2011; Lewis, Nagarajan et al. 2012). 
A known shortcoming of FBA is that it does not account for dilution of 
metabolites involved in active reactions (Benyamini, Folger et al. 2010). These 
metabolites are referred to as active metabolites. Consequently, FBA can fail to require 
the biosynthesis of known essential compounds. For example, the Saccharomyces 
cerevisiae model (Duarte, Herrgard et al. 2004) suffers its highest error rate in predicting 
growth of mutants deficient in quinone biosynthesis. The reason for this error is that FBA 
allows quinones to be recycled in silico, whereas biologically quinones must be 
replenished by S. cerevisiae to overcome their growth-associated dilution. To account for 
growth-associated dilution of active metabolites, we developed limed-FBA. 
2.2 Comparison of method 
Importantly, we designed limed-FBA as a linear program. Linear programs can be 
max
 0
T
v
lb ub
c v
Sv
v≤ ≤
=
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solved robustly and quickly, making limed-FBA a practical solution to account for 
metabolite dilution. An alternative method that has been developed is Metabolite Dilution 
FBA (MD-FBA)(Benyamini, Folger et al. 2010). MD-FBA accounts for metabolite 
dilution by forcing a preset level of dilution for active metabolites. MD-FBA was shown 
to predict mutant growth more accurately than FBA (Benyamini, Folger et al. 2010), but 
it has two major drawbacks. (1) MD-FBA places a lower bound but no upper bound on 
dilution, so it effectively allows unlimited export of all metabolites, which is not 
biologically plausible; and (2) MD-FBA requires a computationally expensive mixed 
integer linear program (MILP), which severely limits its practicality (Benyamini, Folger 
et al. 2010). Perhaps most importantly, limed-FBA displays much higher accuracy in 
predicting gene essentiality in Neurospora, suggesting that it is more accurate in general. 
2.3 Overview of method 
The limed-FBA method works by forcing active metabolites to dilute through an 
additional small dilution flux. We illustrate the difference between limed-FBA and FBA 
in Figure 2. As shown, FBA does not account for metabolite dilution; it allows metabolic 
cycles that lack an input flux (Figure 3A). In contrast, limed-FBA forces dilution of 
active metabolites. This dilution necessitates a counteracting input flux, so limed-FBA 
disallows metabolic cycles that lack an input flux, as shown in Figure 4B. A specific 
example for Neurospora is shown in Figure 5C, which focuses on the gene arg-14 that 
encodes acetylglutamate synthase. This enzyme acts as an input flux to arginine 
biosynthesis and is required for growth (Davis 1979). FBA uses the arginine biosynthesis 
pathway without input flux from acetylglutamate synthase, and thus incorrectly predicts 
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arg-14 is not essential. In contrast, limed-FBA forces dilution of the metabolites in the 
acetyl cycle, thus preventing these compounds from being produced without an input 
flux. As a consequence, limed-FBA correctly predicts that arg-14 is essential.  
 
Figure 6. limed-FBA vs FBA.  (A) FBA does not require an input flux for cycles because it does not account 
for dilution of metabolites that participate in active reactions. (B) limed-FBA requires an input flux for 
cycles to compensate for dilution of metabolites that participate in active reactions. (C) FBA fails to 
correctly predict arg-14 gene essentiality because without an input flux, metabolite dilution prevents the 
isolated acetyl cycle compounds from being produced (side compounds not shown). 
A heuristic that is used in FBA to account for metabolite dilution is to add a small 
“drain” of diluted metabolites to the biomass composition. The issue with this heuristic is 
that it requires knowing a priori which metabolites are diluted, whereas limed-FBA 
determines which metabolites are diluted based on the flux. For example if this heuristic 
was used to add a metabolite in the cycle of Figure 7, such as N-acetyl-L-glutamate, to 
biomass, then FBA would correctly predict the essentiality of arg-14. However, then 
FBA would also predict that the arg-14 knockout cannot be rescued by arginine. In fact, 
arginine does rescue Δarg-14 experimentally, as correctly predicted by limed-FBA. 
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2.4 Details of method 
limed-FBA is a linear method which requires a metabolite’s concentration to 
dilute slightly if and only if it is used in active reactions. We model this dilution 
implicitly by forcing metabolites to compensate for their dilution through accumulation. 
This accumulation can be modeled mathematically using the formalism of FBA, as 
follows.  
Let S be a stoichiometric matrix of irreversible reactions (where reversible 
reactions are represented as two irreversible reactions in opposite directions), v be a 
vector of (non-negative) steady-state metabolic fluxes, and b represent a vector of the 
associated metabolite concentrations changes. Then 
. 
To linearly account for metabolite accumulation, we would like to construct b as a 
linear function of v so that bi is positive but small when metabolite i participates in active 
reactions, and bi is zero otherwise. 
To construct such a b, we first introduce the binary stoichiometric matrix, Sbinary 
(Becker and Palsson 2008), whose element at row i and column j is 1 if and only if the 
corresponding element of S ≠ 0. Now consider Sbinaryv for a particular metabolite i (this is 
row i of Sbinary multiplied by v). Because Sbinary and v are both non-negative, element i of 
Sbinaryv represents the sum of the absolute values of the fluxes that produce and consume 
metabolite i. This quantity is twice the turnover of metabolite i. Thus, if metabolite i does 
not participate in active reactions, then element i of Sbinaryv is zero. Otherwise, if 
Sv b=
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metabolite i does participate in active reactions, then element i of Sbinaryv is positive. 
To ensure that the dilution is small when metabolite i participates in active 
reactions, we multiply Sbinaryv  by ε, where ε is a diagonal matrix whose number of rows 
and columns is the number of metabolites, and its elements, εii, are small non-negative 
constants that correspond to each metabolite i. 
Thus, we set 
ε= .binaryb S v  
We then implement limed-FBA according to 
. 
Note that this equation does not hold for all v; rather, it only holds for those v that are 
feasible in limed-FBA. This equation can be simplified to 
. 
We assign ε so that no metabolite’s dilution rate can exceed a pre-chosen 
constant. Here, we set dilution to never exceed 0.1 mmol/(gDW*hr); this choice gives 
dilution rates on par with those theoretically prescribed by MD-FBA. In general, we 
assign εii to be 
 
max
1
0.1
ii n
binary
ij
j
v S
ε
=
=
∑
  
 
where here n represents the number of reactions, and maxma iixv ub=  is the overall upper 
binarySv S vε=
binary
limed( ) 0S S v S vε− = =
16 
 
bound on the fluxes. We used vmax=1000. 
Metabolites in biomass already dilute according to FBA. So that we do not 
double-dilute biomass metabolites, metabolites whose growth-associated dilution is 
already captured in the pre-defined biomass (e.g. DNA, RNA, protein) are assigned εii=0.  
The use of small numbers such as εii can create numerical difficulties for 
optimization solvers, such as IBM ILOG CPLEX. We found that these errors were rare, 
only occurred when growth was impossible, and disappeared when trying an alternate 
linear programming solution method (e.g. the simplex method instead of a barrier 
method). Choice of the linear programming solution method is a parameter in CPLEX, 
and we tried other parameters, such as numerical emphasis, which were not as effective. 
An alternative that we didn’t try is to use an exact solver or one with more precision 
(Lerman, Hyduke et al. 2012). 
As a consequence of limed-FBA’s linearity, limed-FBA allows more dilution for 
metabolites with more flux. This is associated with a potential pitfall. Consider a 
metabolite that is produced as a by-product of growth, but is not connected to an 
exporter. To maximize growth, this metabolite would need to be depleted. To deplete this 
metabolite, limed-FBA could potentially “cheat”: it could create a high-flux loop that 
includes the metabolite, so that the metabolite is allowed to dilute more. If a reaction 
includes multiple metabolites, then including it in a loop is more likely to have system-
wide effects; conversely, reactions with fewer metabolites are less likely to have system-
wide effects. In accord with this, we found that limed-FBA used simple reversible 
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transport reactions (e.g. L-glutamine[cytosol] ↔ L-glutamine[nucleus]) to “cheat.” To 
address this, we disallow simple transport reactions from contributing towards dilution. 
We define these simple transport reactions as those that transport metabolites, but involve 
no chemical change. This disallowance is implemented mathematically by assigning 
columns in Sbinary that correspond to these simple transport reactions to be all zeroes. If 
this cheating does occur, it allows export of metabolites not connected to an exporter, and 
MD-FBA allows export of all metabolites, so this cheating in limed-FBA is not an issue 
relative to MD-FBA. 
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3 Consistent Reproduction of Growth Phenotype (CROP) 
During stage 2 of our process, we iteratively improved the ability of the metabolic 
network model to predict gene knockout phenotypes. A number of computational 
algorithms have been described to maximize consistency between predicted and 
experimental growth/no-growth phenotypes (Reed, Patel et al. 2006; Henry, Zinner et al. 
2009; Kumar and Maranas 2009; Henry, DeJongh et al. 2010; Zomorrodi and Maranas 
2010; Latendresse, Krummenacker et al. 2012). These algorithms are typically designed 
to optimize a MILP, because they include binary variables to represent whether each 
reaction should or should not be included in the metabolic model. One such MILP-based 
algorithm is the Model SEED (Henry, Zinner et al. 2009; Henry, DeJongh et al. 2010), 
which is a fully-automated model reconstruction process for prokaryotes only. Another is 
GrowMatch (Kumar and Maranas 2009; Zomorrodi and Maranas 2010), which was 
designed to make small changes to models, such as adding or removing up to three 
reactions. One limitation of these approaches is that they do not account for the diverse 
evidence for reactions available for Neurospora, including enzyme function predictions, 
thermodynamic estimates, literature references, and pathway information, in a disciplined 
manner. 
To quickly and accurately reconcile inconsistencies between predicted and 
experimental growth/no-growth phenotypes, we developed Consistent Reproduction Of 
growth/no-growth Phenotype (CROP). CROP solved inconsistencies while accounting 
for diverse evidence. This evidence included (1) whether we had manually curated a 
reaction with experimental evidence from the literature, (2) what pathways a reaction was 
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part of, and whether these pathways were predicted to be in Neurospora (Dale, Popescu 
et al. 2010), (3) thermodynamic estimates of Gibbs free energy, and (4) probabilistic 
estimates of enzyme function. This evidence was mathematically integrated on a 
probabilistic scale to assign each reaction a weight. Our approach to derive weights in a 
disciplined manner was motivated by the statistical maximum a posteriori estimator. 
Thus, the weights have a direct probabilistic interpretation: they depend on the product of 
the probabilities that the reaction is biochemically and thermodynamically plausible. 
These weights guided CROP’s growth reconciliation toward metabolic network changes 
that were most consistent with available evidence. To achieve consistency when the 
model incorrectly predicts growth, CROP suggests reactions from the model to remove. 
To do this, CROP applies MILP. To achieve consistency when the model incorrectly 
predicts no-growth (i.e. to achieve in silico growth), CROP suggests reactions to add 
from a database of metabolic reactions, such as MetaCyc. Previous methods to achieve in 
silico growth used mixed integer linear programming (MILP), and thus required 
substantial compute time (Reed, Patel et al. 2006; Kumar and Maranas 2009; Henry, 
DeJongh et al. 2010). For CROP, we utilize LP relaxation, which is faster by orders-of-
magnitude. 
Our exposition is split into three sections. (1) We describe the novel objective 
function that CROP uses to incorporate diverse evidence. We then describe our complete 
solution in the two situations where CROP is needed: (2) when no-growth is predicted, 
but growth is experimentally observed; and (3) when growth is predicted, but no growth 
is experimentally observed. 
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3.1 Objective function 
CROP maximizes an objective function that has weights associated with each 
reaction. These reactions are represented as being irreversible, where reversible reactions 
are split into two irreversible reactions, so that CROP can also choose among the reaction 
directions.  
We derive the weights using maximum a posteriori (MAP) estimation. This 
estimation requires the probabilities that a reaction is biochemically and 
thermodynamically feasible, because CROP’s purpose is to identify a stoichiometric 
matrix that defines the feasible space of reaction fluxes. 
3.1.1 Probability of biochemical feasibility 
A reaction is biochemically feasible if it can occur. Spontaneous reactions are 
always biochemically feasible. Transport reactions that require a transporter are 
biochemically feasible if and only if the genome encodes the transport function. Non-
spontaneous enzyme-catalyzed reactions are biochemically feasible if and only if the 
genome encodes the enzyme function. The probability that a non-spontaneous reaction is 
biochemically feasible depends on the probability that the genome encodes the required 
function. 
Transport reactions were assigned a probability of one if they had associated 
evidence in NeurosporaCyc; otherwise they were assigned a probability of zero. Non-
spontaneous enzyme-catalyzed reactions were assigned a probability from the enzyme 
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function predictor EFICAz (Arakaki, Huang et al. 2009). When there was additional 
evidence available in NeurosporaCyc, such as genome annotation, pathway prediction, 
and experimental evidence from the literature, this evidence was used to update the 
assigned probabilities. 
3.1.2 Probability of thermodynamic feasibility 
A reaction (in a given direction) is thermodynamically feasible if and only if its 
Gibbs free energy ΔG '<0. ΔG '  is a function of the Gibbs free energy at standard state 
ΔG ' 0 and of the substrate/product concentrations. This function is ΔG '= ΔG ' 0+RTln(Q), 
where R is the gas constant, T is the temperature in degrees Kelvin, and Q is the mass-
action ratio. For a biochemical equation of the form aA + bB →cC + dD, we have: 
0 [ ] [ ]' '
[ ] [ ]
c d
a b
C DG G RTln
A B
⎛ ⎞
⎜ ⎟
⎝
Δ Δ +
⎠
=   (1). 
We can estimate ΔG '  from estimates of ΔG ' 0 (Jankowski, Henry et al.) and from 
physiological ranges of metabolite concentrations. We can further assess the variance of 
ΔG '  from the variance of ΔG ' 0. Taken together, we can use the approach of Fleming et 
al. (Fleming, Thiele et al. 2009) to estimate the probability that a given reaction direction 
is thermodynamically feasible. 
Yet, when using this approach, we found that thermodynamically infeasible 
reactions were not sufficiently penalized, so we developed a novel way to estimate the 
probability that a given reaction direction is thermodynamically feasible. The reason that 
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thermodynamically infeasible reactions were not sufficiently penalized was because 
metabolite concentrations were allowed to freely vary within the physiological range. We 
could not address this problem directly, because we do not have comprehensive 
measurements of metabolite concentrations across conditions. We do not even have 
comprehensive measurements of concentrations of cofactors, such as ATP, across 
conditions. This situation applies to all organisms, not only Neurospora (Bar-Even, Noor 
et al. 2011).  
However, metabolite concentrations enter into (1) as ratios, not as absolutes. And 
these ratios -- such as NAD+/NADH, NADP+/NADPH, and ATP/ADP -- are bounded 
above and below by thermodynamics (Henry, Jankowski et al. 2006). Thus, we used 
known bounds on the ratios of currency metabolites to bring our thermodynamic 
probability estimates more in line with known thermodynamic feasibility. To illustrate, 
consider the reaction: glyoxylate + NADPH + H+ à glycolate + NADP+, with ΔG ' 0 
estimate -7.68 kcal/mol. We have:  
[ ][ ][ ]'
[ ][ ]
7.68 glyoxylate NADPH HG RTln
glycolate NADP
+
+
⎛ ⎞
− ⎜ ⎟
⎝
= +
⎠
Δ . 
The maximum thermodynamic ratio of [NADP]/[NADPH] has been estimated to 
be 1.1 (Jankowski, Henry et al.), and it is thought that organisms try to maintain this ratio 
near its maximum. Thus, we assumed that in the cytosol [NADP]/[NADPH]=1.1. To 
estimate ΔG '  we also assumed a neutral pH (i.e. [H+]=10-7). 
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Now, we can use the physiological range of metabolite concentrations to constrain 
[glyoxylate] and [glycolate]. But since we’ve already used the maximum thermodynamic 
ratio of [NADP]/[NADPH], our confidence interval for 'GΔ  is much tighter, so the 
probability estimate is much more reliable. To our knowledge, using thermodynamic 
bounds on metabolite concentration ratios to obtain more accurate probabilistic estimates 
of thermodynamic feasibility is novel. 
3.1.3 Maximum a posteriori (MAP) estimation 
Our derivation of weights associated with each reaction is motivated by MAP 
estimation. The reactions are irreversible reactions from a metabolic database, such as 
MetaCyc. We begin by defining a binary variable Zi for each reaction i that denotes 
whether it is physiologically feasible for Neurospora to carry flux through reaction i in a 
condition: 
physiologically1 reaction  is feasible
0 otherwisei
Z
i⎧
= ⎨
⎩
. 
Zi=1 corresponds to the event that reaction i belongs in the “true” metabolic network. 
Thus, CROP’s purpose is to decide which Zi’s should be one and which should be zero; 
this decision specifies the metabolic network. 
24 
 
We relate our data on probabilities of biochemical and thermodynamic feasibility 
(described above) to probabilities of physiological feasibility.  
(reaction  is feasible)
(reaction  is biochemically and thermodynamically feasible)
(reaction  is biochemically feasible) (reaction
physiological
  is thermodynamically feasibl
ly
e)
i
i
i
p P i
p P i
p P i P i
=
=
=
 
We then use our data pi to formulate the MAP estimate for the vector of Zi’s. This vector 
estimate is denoted by 
^
Z . This gives: 
^
argmax ( | )
i
i i
Z i
Z P Z p= ∏   (2) 
^
argmax ln[ ( | )]
i
i i
Z i
Z P Z p= ∑   (3) 
The trivial solution to this equation is to choose Zi=1 for those reactions where pi>0.5 
and Zi=0 otherwise, but we’d like to use this equation in a constrained optimization that 
also accounts for network connectivity, so we proceed to simplify it. 
By definition of pi, we know that: 
( 1| )i i iP Z p p= =      (4) 
and similarly, 
( 0 | ) 1i i iP Z p p= = −   (5). 
25 
 
Now, we represent ( | )i iP Z p  as a mixture model, which “mixes” the cases where 
Zi=1 and Zi=0: 
( )
( | ) ( 1| ) (1 ) ( 0 | )
( | ) (1 ) 1 .
i i i i i i i i
i i i i i i
P Z p Z P Z p Z P Z p
P Z p Z p Z p
= = + − =
= + − −
 (6) 
We log-transform (6) to obtain a form that matches (3),  
[ ] ( )ln ( | ) ln (1 ) 1i i i i i iP Z p Z p Z p⎡ ⎤= + − −⎣ ⎦   (7). 
We would like to optimize (7), as shown in (3), with constraints regarding the 
network properties. (The full optimization is discussed in the sections below.) Because 
the Zi variables are binary, this optimization problem is very computationally demanding 
– in fact, it is NP-hard. So that this already demanding optimization problem is tractable 
using available solvers, its objective function must be linear or quadratic, and for speed, it 
is desirable for it to be linear. 
So we sought a linear approximation to (7). To model this logarithmic function as 
a linear one, we appeal to the logarithm’s first-order Taylor series approximation around 
0: ln(1+x)≈x for -1<x≤1. Thus, 
( ) [ ]
( )
ln (1 ) 1 ln 2 1
ln (1 ) 1 2
i i i i i i i i
i i i i i i i i
Z p Z p Z p Z p
Z p Z p Z p Z p
⎡ ⎤+ − − = + − −⎣ ⎦
⎡ ⎤+ − − ≈ − −⎣ ⎦
  (8). 
To exclude the possibility that ( )(1 ) 1 0i i i iZ p Z p+ − − = , which would pose a 
problem for the logarithm, we only need to assume that 0<p<1. 
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We now put the above steps together to show our linear approximation for the 
MAP estimate: 
^
argmax ln[ ( | )]
argmax 2
argmax 2
argmax (2 1)
i i
Z i
i i i i
Z i
i i i
Z i
i i
Z i
Z P Z p
Z p Z p
Z p Z
Z p
=
≈ − −
= −
= −
∑
∑
∑
∑
  (9) 
where terms without Zi were removed, because they are not involved in the optimization. 
We simplify by multiplying through by 1/2,  
( )
^
argmax 0.5i i
Z i
Z Z p≈ −∑ , 
which can be stated in matrix notation as: 
( )
^
argmax 0.5
Z
Z Z p≈ −   (10). 
This implies that our objective function is: ( )0.5Z p − . 
3.2 Resolving incorrect predictions by restoring growth  
In this section, we mathematically deal with conditions where no-growth is 
predicted, but growth is experimentally observed. (A condition is defined by what genes 
are knocked-out and what nutrients are available.) Thus, the goal here is to identify model 
changes that restore growth in a given condition. 
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There are several model changes that can restore growth. One model change that 
can restore growth is to assign a knocked-out gene an isozyme, so that the gene knockout 
does not lead to reaction removals. This change is implemented by modifying the gene-
protein-reaction (GPR) associations. Another model change that can restore growth is to 
remove metabolites from the biomass composition, since this reduces the requirements 
for growth. This is implemented by changing the biomass composition in the 
stoichiometric matrix. If neither of these model changes were appropriate, we sought to 
restore growth by adding reactions to the model from MetaCyc or from NeurosporaCyc 
reactions that were not in the model. To identify the reactions to add to the model to 
restore growth, we implemented an optimization.  
This optimization can be modeled as a large mixed-integer linear program 
(MILP). Consider a stoichiometric matrix S with irreversible reactions from a model and 
from a database, a vector of binary variables z with associated non-negative weights 
corresponding to reactions in the database, and a vector of reaction upper bounds U . For 
example, consider U. If the condition limits the glucose uptake reaction to 10, then we set 
Uglucose=10, and for all other reactions we set U=1000, as a loose upper bound. If the 
condition includes a gene knockout, then for reactions KO that require the gene, we set 
UKO=0. Now, assume that the ATP flux must be at least atp_maintenance, and that 
growth, represented by vbiomass, must be at least minimal_growth. Then, the general form 
of the MILPs is: 
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0
0 for model
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i i
i i i
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Sv
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v U z i
v
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z
=
≤ ≤ ∈
≤ ≤ ⋅ ∈
≥
≥
∈
  (11). 
The main difference between MILPs is how they assign weights for reactions 
from the database. GrowMatch (Kumar and Maranas 2009) treats all reactions as having 
the same weight, so it minimizes the total number of reactions to add. The Model SEED 
(Henry, Zinner et al. 2009; Henry, DeJongh et al. 2010) assigns these weights based on 
diverse evidence. Since there is one binary variable per reaction in the database, these 
MILPs can be very large, so they are time-consuming to solve. 
Our formulation is similar to program (11). Since program (11) is a minimization, 
the weights in our objective function (derived in the previous section) would be 0.5-p. To 
exploit the structure of program (11) for efficient solving, though, we require that our 
weights be non-negative, so that they serve as penalties. Then, we can seek to identify the 
path of least resistance through penalized reactions. So, we slightly modify our objective 
function, and instead use: 1weights p= − , where 0<p<1.  
With non-negative weights, we are able to solve in only a few seconds by first 
solving a linear relaxation of the MILP. This linear relaxation allows all of the variables 
zi, which were formerly restricted to be binary, to lie anywhere between 0 and 1, inclusive 
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(i.e. anywhere in [0,1]). Solving this linear relaxation is very fast, since it is a linear 
program.  
The idea behind this linear relaxation is that it minimizes a weighted sum of flux 
through the database reactions. Thus, reactions not assigned flux in the relaxation are not 
needed to restore growth; conversely, reactions assigned flux are likely to have a low 
weight and contribute to restoring growth. Then, the set of reactions whose zi>0 in the 
linear relaxation becomes the set of reactions to add to the model, and these reactions 
restore growth.  
This set of reactions returned by the relaxation -- the relaxation set -- is not 
necessarily optimal for (11). However, we found this set of reactions to be very similar to 
the optimal set in practice, and furthermore we could efficiently improve the set in two 
ways. (I) We can treat the relaxation set as if it were the set of all database reactions, and 
then optimize program (11) normally. Because the relaxation set is much smaller than the 
set of all database reactions, this optimization runs remarkably quickly. (II) We can solve 
program (11) using the relaxation set as a high-quality feasible starting point (often 
called a warm-start), which can save the optimizer substantial computational time 
(Mitchell 2001). 
3.3 Resolving incorrect predictions by suppressing growth 
In this section, we mathematically deal with conditions where growth is predicted, 
but no growth is experimentally observed. Thus, the goal here is to identify model 
changes that suppress in silico growth in a given condition. Importantly, these model 
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changes should not have the side-effect of suppressing growth in other conditions where 
growth is experimentally observed, such as the condition of wild-type in minimal 
medium. 
There are several model changes that can suppress growth. These are basically the 
reverse of those that restore growth. If the knocked-out gene encodes an isozyme, then 
removing its isozyme, or requiring both gene products as subunits of an enzyme complex, 
will lead to reaction removal. Reaction removal can suppress growth if the reaction is 
essential. Another model change that can suppress growth is to add metabolites to the 
biomass composition, since this increases the requirements for growth. These two model 
changes can also be implemented together. However, if neither of these model changes 
were appropriate, we sought to suppress growth by removing reactions from the model. 
To identify the reactions to remove from the model to suppress growth, we implemented 
an optimization.  
To illustrate the principles involved in the optimization, we first provide a generic 
optimization-based solution strategy. We then compare the generic strategy to the 
optimizations of GrowMatch (Kumar and Maranas) and Model SEED (Henry, Zinner et 
al. ; Henry, DeJongh et al.). GrowMatch, Model SEED, and CROP all solve this problem 
using a large mixed integer linear program (MILP).  
All of these MILPs involve the dual linear program to FBA. The dual linear dual 
linear program to FBA is required, because it provides an upper bound on growth, and 
no-growth is characterized by an upper bound on growth of zero. If these programs tried 
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instead to simply set the FBA growth flux to zero, these programs would only represent 
that no-growth was feasible; they would not represent that growth is infeasible. 
3.3.1 Generic solution strategy 
This strategy independently examines each condition where growth is predicted, 
but no growth is experimentally observed. For each such condition, a bi-level MILP is 
created. The purpose of this MILP is to find the optimal set of reactions to remove such 
that in silico growth becomes infeasible in this condition, but remains feasible for a set of 
control conditions, such as wild-type in minimal medium. 
This MILP has the same variables as described previously: S, U, z, weights, 
minimal_growth, and atp_maintenance. However, there are now two conditions: the 
condition where no growth is experimentally observed, and wild-type in minimal 
medium. Then, the vector v represents flux for the condition where no growth is 
experimentally observed, and has upper bounds Uno-growth; the vector w represents flux for 
wild-type in minimal medium, and has upper bounds Uwt. 
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 (12) 
The outer minimization problem represents the modeler's optimization to find the 
optimal set of reactions to remove such that in silico growth represented by vbiomass, falls 
below minimal_growth. The constraint vbiomass≤minimal_growth implies that when there 
are no solutions that reduce growth to minimal_growth, program (12) will not report on 
solutions that partially reduce growth. However, such solutions may be helpful in cases 
where no complete solutions can be identified.  
The inner maximization problem of (12) represents FBA, although without the 
requirement for ATP. We removed this requirement, because it may not be satisfied in 
the no-growth condition. 
Program (12) is a bi-level MILP. To transform it into a single-level MILP, the 
inner maximization problem must be transformed into a set of constraints. This has been 
done using an ingenious technique proposed by Maranas’ lab (Burgard and Maranas) 
based on the strong duality theorem of linear programming. In this technique, the inner 
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problem is transformed into a set of constraints by including the constraints of the inner 
problem’s dual, and then constraining the objectives of the inner problem and the inner 
problem’s dual to be equal. 
Before illustrating the primal and dual formulations when z is included, we first 
show this without z for simplicity. Without z, the primal is FBA. To represent FBA in a 
way that will simplify the derivation of its dual, we represent FBA without unnecessary 
bounds. So if there is only a single limiting nutrient, e.g. vglucose≤10, then we represent 
FBA with no other upper bounds. Moreover, vglucose does not need an explicit lower bound 
of zero, because it will never be negative. As with the inner problem above, we also 
remove the ATP maintenance requirement. Then, the form of the primal LP is: 
biomass
glucose
max
0
0 for glucose
10
T
v
i
c v v
Sv
v i
v
=
=
≤ ≠
≤
 
Now, we need the dual. The reason we need the dual is because we want to model 
an upper bound on growth. To derive the dual, we follow the approach in (Boyd and 
Vandenberghe 2004), which uses the  Lagrangian L: 
glucose glucose
i glucose
glucose
(10 )
10 ( )
T
i i
T
L c v mSv r v r v
L r c S m r v
≠
= + − ⋅ + ⋅ −
= + + −
∑
 
Then, the Lagrangian dual problem is: 
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which is equivalent to: 
glucose,
glucose
min  10
0
0 for glucose
m r
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r
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r
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≤ ≠
 (13) 
where ST is the transpose of the stoichiometric matrix S, r is the dual variable associated 
with reaction constraints (e.g. v≥0 and vglucose≤10), and m is the dual variable associated 
with metabolite constraints (i.e. a row of Sv=0). 
Now we address the case where there is a binary decision variable per reaction, z. 
To include z in the optimization, we need a loose upper bound, U. U is required to be 
sufficiently large such that the constraint vi≤Uizi does not affect the optimum when zi=1. 
Then, the primal becomes: 
biomassmax
0
0 for all
T
v
i i i
c v v
Sv
v U z i
=
=
≤ ≤ ⋅
 (14) 
where i indexes reactions and Uglucose=10. The dual to this problem is: 
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 (15) 
where Ωi represents a loose upper bound on the elements of the vector r, e.g. Ωi=1000. 
This dual formulation is linear when we treat z as a parameter “passed in” from the outer 
problem to the inner problem. However, the objective is nonlinear in the integrated 
single-level model, where we include z as a decision variable along with r. 
Maranas’s lab has previously shown that they can resolve the nonlinearity in (15) 
when z is included as a decision variable (Burgard and Maranas 2003). However, the 
solution is highly non-trivial, and we are not aware of any publication that derives it. We 
infer that they resolved this nonlinearity by exploiting the fact that Uiziri=0 for all 
reactions i except i=glucose. Uiziri=0 for all these reactions, because Uiziri=0 when zi=0 
and when zi=1. If zi=0, then Uiziri=0 trivially. If zi=1 in (14), then the upper bound 
constraints on vi will not be tight, since Ui is sufficiently large by design. Constraints that 
are not tight have dual variables of zero, so if zi=1, then ri=0, implying that Uiziri=0. The 
reaction i=glucose is slightly different. This reaction is required, so we know it will be 
included in the model. Thus, we know that zglucose=1, so zglucose no longer becomes a 
decision variable. Furthermore, because glucose is the limiting nutrient, we know that 
vglucose=Uglucose=10, so its upper bound Uglucose=10 is tight. Tightness of this upper bound 
implies that rglucose≥0.  
By exploiting the behavior of Uiziri, program (15) can be represented as,  
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Program (16) does not possess the nonlinearity of program (15). Thus, program (16) can 
be used to transform program (12) into a single-level MILP, by transforming the inner 
problem into a set of constraints. 
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(17) 
3.3.2 GrowMatch 
The main difference in these conditions between the generic solution strategy 
given in program (17) and GrowMatch (Kumar and Maranas 2009; Zomorrodi and 
Maranas 2010) concerns how minimal_growth is obtained and what its outer problem 
minimizes. The generic solution strategy constrains vbiomass≤ minimal_growth, and its 
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outer problem minimizes a weighted sum of reactions. Instead, GrowMatch’s outer 
problem minimizes growth, and it constrains the number of gene/reaction removals. This 
implies that GrowMatch again treats all reactions as having the same weight. In their 
original paper, they constrained the number of reaction removals per condition to be three 
(Kumar and Maranas 2009). In their subsequent paper, they constrained the number of 
gene/reaction removals per condition to be two (Zomorrodi and Maranas 2010).  
3.3.3 Model SEED 
The main difference in these conditions between the generic solution strategy 
given in program (17) and the Model SEED (Henry, Zinner et al. 2009; Henry, DeJongh 
et al. 2010) is the formulation of the dual in the inner problem. The Model SEED’s dual 
to FBA has an unexpected form.  
Putting their dual to FBA into our nomenclature, we get: 
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 (18) 
where K is a large positive constant (e.g. 10,000). Since program (18) is meant as the dual 
of FBA, we expect its dual to be FBA. For comparison, FBA for irreversible reactions is 
given in program (14). However, when we calculate the dual of program (18), we find: 
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where τ and σ are slack variables, z is treated as a parameter that is “passed in” from the 
outer problem, and vbiomass=cTv. Program (19) is not FBA.  
This is a problem, because the Model SEED constrains the objective value of 
program (18) to be equal to the objective value of FBA, whereas the strong duality 
theorem of linear programming equates the objective value of program (18) and the 
objective value of program (19). Thus, if the objective value of program (19) differs from 
the objective value of FBA, then the Model SEED’s MILP is infeasible. 
We refer to program (19) as a softly-constrained version of FBA. To see that it’s 
softly-constrained, consider the case where only a single reaction i is removed. This is 
represented as zi=0. In FBA, shown in program (14), we have 0≤vi≤Uizi, so vi=0. 
However, in this case, program (19) becomes: 
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− −
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Now vi can be positive if the objective pays a penalty of Kvi. So zi=0 acts as a soft 
constraint. Now, consider a single reaction j with zj=1. Similarly, we see that vj can 
exceed its upper bound Uj by τj if the objective pays a penalty of Kτj. So Uj also acts as a 
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soft constraint. Thus, program (19) treats the constraint v≤Uz as a soft constraint in 
general. 
To characterize when v>Uz, consider the case where increasing the flux through a 
single reaction l from vl=Ulzl to vl=Ulzl+Δvl increases growth by Δvbiomass. Then, we know 
that program (19) will penalize the objective by KΔvl. Thus, it will only be optimal for vl 
to increase if Δvbiomass>KΔvl, or equivalently if Δvbiomass/Δvl>K. This inequality represents a 
small additional flux substantially adding to growth.  
It is unclear how many reactions in the Model SEED’s database can have 
Δvbiomass/Δvl>K. In our model, we see Δvbiomass/Δvl>100, for example with MYO-
INOSITOL-1-PHOSPHATE-SYNTHASE. This reaction has a large Δvbiomass/Δvl, because 
myo-inositol is needed in small quantities for growth.  
The possibility of Δvbiomass/Δvl>K argues for increasing K in program (19). The 
problem with increasing K, though, is that optimization solvers have limited numerical 
precision, and large numbers in an optimization can have detrimental effect on the 
precision of small ones. However, difficulties with numerical precision of fluxes with 
high Δvbiomass/Δvl is not limited to the formulation in program (19). In fact, we had trouble 
ensuring that the constraint v≤Uz was enforced strictly, because solvers by default 
typically allow constraints to be violated by a small margin, such as 10-6. 
We emphasize that this discussion does not nullify any of the Model SEED’s 
wonderful results; rather, it suggests that fully automated model reconstruction pipelines 
can still improve. Unfortunately, I did not have the opportunity to modify the Model 
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SEED’s algorithm “in-place” on their servers to identify concrete examples of how this 
modeling error affects their final models, but if they were to correct their formulation, 
they would likely find that metabolic models for some organisms would better predict 
that organism’s essential genes. 
3.3.4 CROP 
There are three main differences in these conditions between the generic solution 
strategy given in program (17) and CROP. The differences concern CROP’s (A) 
robustness to unbalanced reactions, (B) its smaller size, and (C) its ability to handle 
multiple conditions simultaneously.  
A. Robustness 
CROP was designed to be robust to unbalanced reactions, because we had 
unbalanced reactions in our database of metabolic reactions. These unbalanced reactions 
arose because of difficulties in exporting the MetaCyc reaction to text files, or because a 
reaction was unbalanced in MetaCyc. Other metabolic reaction databases, such as the 
Model SEED’s biochemistry database and KEGG, also have unbalanced reactions. 
Although the existence of such unbalanced reactions is known (Gevorgyan, 
Poolman et al. 2008), we are not aware of any reconstruction algorithm that accounts for 
them when trying to suppress in silico growth. It was not feasible to manually balance all 
of the unbalanced reactions in our database. Instead, we had to select which of these 
reactions may belong in our final model.  
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We could not use previous algorithms to select among these unbalanced reactions. 
To see this, consider the Generic solution strategy. It assumes that the only upper bounds 
for FBA are those on limiting nutrients, such as glucose. However, an unbalanced 
reaction could have the form: water → glucose, and therefore act like the limiting 
nutrient. Because this unbalanced reaction wouldn’t have an upper bound according to 
the Generic solution strategy, its FBA would be unbounded. (Furthermore, we could not 
treat these reactions like nutrient sources, because doing so implies that we wouldn’t have 
any decision variable associated with these reactions, so wouldn’t be able to select which 
belonged in the final model.) 
For CROP to be robust to unbalanced reactions, we developed a new version of 
FBA. This version of FBA is called Digital Unlimited-Nutrient Growth FBA (dung-
FBA). dung-FBA is never unbounded, no matter how many unbalanced reactions there 
are, because it imposes an upper bound on growth: vbiomass≤1. In fact, this is dung-FBA’s 
only upper bound. dung-FBA allows unlimited uptake of the available nutrients, so that 
the only factor limiting growth is connectivity. This feature is similar to OnePrune. 
Moreover, this allows dung-FBA to yield a binary (digital) result to the question: is 
growth possible? Mathematically, dung-FBA is defined by the following linear program:  
biomassmax
0 (dung-FBA)
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1
T
v
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c v v
Sv
v
v
=
=
≤
≤
  
For CROP’s MILP, CROP requires the dual of dung-FBA. This dual is: 
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where r is the dual variable associated with reaction constraints, and m is the dual 
variable associated with metabolite constraints. Now we add binary decision variables, z, 
so that we can select reactions to remove. dung-FBA now becomes: 
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where Ubiomass=1. The dual of this program is: 
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For reactions i that are knocked out as a result of a gene knockout, zi is treated as 
0, implying ri ≤ Ωi. Since Ωi is supposed to be a loose upper bound, we represented this as 
ri being free. 
We used dung-FBA along with limed-FBA by replacing the S in dung-FBA with 
limed-FBA’s Slimed. Using dung-FBA successfully brought us robustness to unbalanced 
reactions. 
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B. Size 
FBA maximizes growth, so its dual represents an upper bound on growth. Thus, 
to mathematically express the experimental observation of no-growth (or of growth 
below a threshold), we need the dual. However, it also follows that once we have the 
dual, we no longer need FBA. In fact, incorporating both FBA and its dual only provides 
value if we want to model an intermediate level of growth. This observation appears to 
have been overlooked. However, only using the dual substantially reduces the MILP’s 
size. 
This observation is actually suggested by program (17) in Generic solution 
strategy. Program (17) includes the constraints vbiomass=10rglucose and it includes 
vbiomass≤minimal_growth. Together, these constraints imply that 10rglucose≤minimal_growth, 
and that we can ignore vbiomass. When we remove FBA’s growth maximization from the 
inner problem of program (17), we get: 
( )
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One issue with the Generic solution strategy is that when there are no solutions 
that reduce growth to minimal_growth, solutions that partially reduce growth are not 
reported. To overcome this issue, rglucose can be moved to the objective. 
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 where the constant B balances (i) the model’s consistency with reaction weights versus 
(ii) consistency with growth phenotypes. 
Now, we replace the dual of FBA with the dual of dung-FBA, which involves 
substituting rglucose with rbiomass: 
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A numerical difficulty that arises is that although zi is supposed to be binary, its 
value may differ from 0 or 1 by a small amount, such as by 10-6. Thus, even when zi is 
supposed to be 1, ri may not be forced to be negative, but may instead reach 10-6 ⋅Ωi. To 
mitigate the effects of such numerical difficulties, we had some success with using rather 
small Ωi for all reactions, e.g. Ωi=1. We found that using such tight upper bounds also 
improved run-time, which is consistent with the findings of others (Kim and Reed 2010). 
This section shows that CROP deals with conditions where growth is predicted 
but no growth is experimentally observed with a MILP that is much smaller than previous 
algorithms, allowing for more efficient solution. 
C. Handling multiple conditions simultaneously 
Facilitated by its robustness and smaller size, CROP can handle multiple 
conditions where no growth is experimentally observed simultaneously. For two 
conditions where no growth is experimentally observed, the MILP is similar to above, 
albeit with an additional dual. 
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Handling multiple conditions simultaneously allows for identification of model 
modifications that parsimoniously solve these multiple conditions. 
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4 One-step Functional Pruning of Metabolic Networks (OnePrune) 
After iteratively applying CROP to improve the model, reactions can be present that 
cannot carry flux under any nutrient condition. These reactions are referred to as blocked 
reactions. The removal of blocked reactions is a process known as functional pruning 
(Hoffmann, Hoppe et al. 2007). Blocked reactions are often identified according to Flux 
Variability Analysis (Mahadevan and Schilling 2003; Gudmundsson and Thiele 2010), 
however this requires optimizing each reaction separately. An alternative approach 
(Jerby, Shlomi et al. 2010) identifies blocked reactions by successive linear programs, 
although it is unknown in general how many LPs are necessary. We developed an 
algorithm to perform functional pruning with a single compact linear program, OnePrune. 
Conceptually, OnePrune is based on the optimization approach called goal programming 
(Tamiz, Jones et al. 1995).  
OnePrune was developed to efficiently solve the problem of removing reactions that 
are blocked. OnePrune utilizes the goal programming optimization framework to achieve 
multiple competing objectives. The advantage of this framework is that once an 
individual objective is achieved, the optimization can pursue other objectives. OnePrune's 
goals are to send flux through as many reactions as possible, so once a reaction has 
achieved a nonzero flux, OnePrune is free to pursue flux through other reactions. Thus, 
OnePrune identified which reactions could carry flux with a single compact linear 
program. 
Mathematically, it’s defined as a linear goal program: 
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where S is a stoichiometric matrix consisting of n irreversible reactions. This program 
does not contain upper bounds on the available nutrient sources, so the only factor 
limiting reaction flux is connectivity. Thus, in the optimal solution, all ti’s should be 
binary: reactions with ti of one can carry flux, while the other reactions are blocked. 
OnePrune requires an irreversible stoichiometric matrix, but any reversible 
stoichiometric matrix can be transformed into an irreversible one (by splitting reversible 
reactions into two irreversible reactions of opposite direction) so this method is 
completely general. This requirement exists because direct inclusion of a reversible 
stoichiometric matrix would force OnePrune to deal with absolute values of reaction flux 
in a manner not amenable to linear programming (Shanno and Weil 1971). Moreover, 
only an irreversible stoichiometric matrix allows OnePrune to distinguish between 
different directions of the same reaction. 
The set of blocked reactions of an irreversible stoichiometric matrix may differ 
slightly from those of a reversible stoichiometric matrix. For example, consider a 
reversible reaction between two metabolites disconnected from the metabolic network: A 
↔ B. In an irreversible stoichiometric matrix, this would be modeled as two reactions: A 
→ B and A ← B. Thus, the reversible reaction is blocked, whereas the two irreversible 
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reactions could carry flux as part of a flux cycle according to FBA. To address this, we 
implemented OnePrune according to limed-FBA by using Slimed as the stoichiometric 
matrix. This implementation disallows cycles that lack an input flux, so it disallows the 
cycle of A → B and A ← B. However, limed-FBA does allow some cycles—namely, 
those not penalized in Slimed and those that have an input flux. Thus, reversible reactions 
that form such cycles (e.g. A[cytosol] ↔ A[extracellular]) will not be pruned by 
OnePrune. However, these reversible reactions can be identified a priori and addressed 
with Flux Variability Analysis (Mahadevan and Schilling 2003; Gudmundsson and 
Thiele 2010) or the method of Jerby et al. (Jerby, Shlomi et al. 2010). Furthermore, 
reversible reactions that form such cycles are rare, and we found that OnePrune’s 
determination of blocked reactions was identical to that of Flux Variability Analysis in 
practice.  
To apply OnePrune to achieve our final pruned model, we allowed all 
extracellular metabolites in our model to be treated as nutrients. 
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5 Reconstruction of a genome-scale metabolic model for Neurospora crassa 
5.1 Overview of Neurospora metabolic network model 
Here we describe the results of our genome-scale metabolic reconstruction and its 
application as a predictive steady-state model. Following the accepted nomenclature 
(Reed, Vo et al. 2003) for naming metabolic models, we call the model N. crassa 
iJDZ836. N. crassa iJDZ836 is available in the Systems Biology Markup Language 
(SBML). 
The model contains 836 genes that encode 1027 unique enzymatic activities. Of 
these enzyme-catalyzed reactions, 694 are supported by experimental evidence from 491 
publications addressing Neurospora-specific enzymes. This level of evidence compares 
favorably with other highly curated models (Andersen, Nielsen et al. 2008; Orth, Conrad 
et al. 2011; Heavner, Smallbone et al. 2012) as shown in Table 1.  In addition, 16 
spontaneous reactions and 331 orphan reactions were included based on the literature 
(Karp 2004; Chen and Vitkup 2006; Chen and Vitkup 2007). 
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Table 1. Comparison of curation level among selected metabolic models. 
 N.crassa 
iJDZ836 
A.niger 
iMA871 
Yeast 5.0 E.coli iJO1366 
Number of 
organism-specific 
citations 
491 371 385 447 
Coverage 47% 47% 37% 46% 
Coverage is the percentage of enzyme-catalyzed reactions that are supported by organism-
specific experimental evidence 
Our model contains 737 chemically unique metabolites. Of these metabolites, 673 
have a defined structure that permits estimates of Gibbs free energy (Jankowski, Henry et 
al. 2008; Noor, Bar-Even et al. 2012). Using these Gibbs free energy estimates, 1046 
biochemical reactions were thermodynamically constrained to be irreversible, while the 
remaining 328 were assumed to be reversible. Of the 294 biochemical reactions that were 
associated with multiple proteins, 47 were manually curated as being catalyzed by an 
enzyme complex; we assumed the rest were catalyzed by isozymes. There are 257 
metabolic pathways in the model. Of these, 134 are biosynthesis pathways, 96 are 
degradation/utilization/assimilation pathways, and 27 are pathways involved in the 
generation of precursor metabolites and energy. An overview of the pathways is 
displayed in Figure 8 and a zoomable metabolic map of the pathways is shown in Figure 
S3. 
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Figure 9. Metabolic overview of Neurospora crassa.  The 257 metabolic pathways of Neurospora are divided 
into the 35 color-coded pathway classes. Biosynthetic pathways are displayed on the left, energy 
metabolism in the center, and degradation pathways are on the right. In addition to the cytosol and 
extracellular space, the model also contains 4 organelles: these are the vacuole, the nucleus, and the 
mitochondrion. The 299 transport reactions enable uptake and excretion of 137 metabolites and also 
exchange between the cytosol and each organelle. 
Cellular compartments in the model include the cytosol, the extracellular space, 
and 4 organelles: the glyoxysome, the vacuole, the nucleus, and the mitochondrion. The 
299 transport reactions of the model enabled not only uptake and export of 137 
metabolites, but also the exchange of metabolites between the cytosol and each organelle. 
The model's growth objective was based on a modular biomass composition 
(Beste, Hooper et al. 2007; Feist and Palsson 2010). Biomass modules were separately 
defined for DNA, RNA, amino acids, cell wall, lipids, sterols, essential cofactors, and 
secondary metabolites. This modular decomposition allowed for different goals in 
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different applications of the model. For example, wild-type biomass contains substantial 
amounts of secondary metabolites, such as sphingolipids, ergosterol and carotenoids 
(which give Neurospora its characteristic orange color), so we included the secondary 
metabolites module in the biomass composition when predicting wild-type fluxes. On the 
other hand, secondary metabolites are not strictly required for viability, so we removed 
this module from the biomass composition when predicting viability. 
The model quantitatively captures the growth rate of Neurospora. To illustrate 
this, we have plotted a range of glucose uptake rates against the model’s predicted 
doubling times, and several data points extracted from the experimental literature 
(Neville, Subkind et al. 1971; Schneider and Wiley 1971; Courtright 1975) (Figure S4). 
The figure shows that our predictions closely match the experimental data. 
5.2 Model validation using gene essentiality 
To validate the accuracy of the N. crassa iJDZ836 model, we manually curated a 
collection of mutant viability phenotypes from the literature. We split this collection into 
a training set, which we used with FARM to construct the model; and an independent test 
set, which we used to validate the final model. Both of these collections are available in 
Table S1. To simulate gene knockout experiments, we removed reactions from the model 
that depend on the gene, applied limed-FBA, and predicted whether or not the perturbed 
model could grow. We then compared experimental observations to the model’s in silico 
predictions. Accuracy was measured as two quantities: sensitivity and specificity. 
Sensitivity was defined as the proportion of experimentally viable mutants that were 
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predicted to be viable in silico. Specificity was defined as the proportion of 
experimentally inviable mutants that were predicted to be inviable in silico. 
The final model’s predictive accuracy using limed-FBA is shown in Figure 10A. 
On the training set, we correctly predicted growth in 107 of 108 experimentally viable 
gene knockouts (sensitivity=99.1%), and we correctly predicted no-growth in 44 of 47 
experimentally lethal mutants (specificity=93.6%). On the test set, we correctly predicted 
270 of 289 experimentally viable gene knockouts (sensitivity=93.4%), and we correctly 
predicted 13 of 14 experimentally lethal mutants (specificity=92.9%). 
The final model’s predictive accuracy on the test and training sets using FBA and 
MD-FBA is shown in Figure 11B. Both of these methods are generally outperformed by 
limed-FBA.  
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Figure 12. Minimal media gene essentiality predictions.  We curated a collection of mutant viability 
observations on minimal media and separated the collection into a training set, where knowledge of the 
viability phenotype was used to improve the model; and a test set, where the viability phenotype was 
hidden from the model. (A) Training and test set mutant viability observations were used to measure the 
sensitivity and specificity of the limed-FBA gene knockout viability predictions. While some 
inconsistencies were due to model error, several were resolved in the model’s favor, as discussed in the 
text. (B) Using the same model, training and test sets, limed-FBA outperforms FBA and MD-FBA. (C) For 
comparison, we display the mutant viability prediction accuracies of previously published FBA models for 
S. cerevisiae and E. coli. Prediction accuracies of experimentally observed viability phenotypes that were 
used to optimize the model are displayed on the left panel (Kumar and Maranas 2009; Zomorrodi and 
Maranas 2010). Prediction accuracies of viability phenotypes that were not explicitly used to construct the 
model are displayed on the right panel (Orth, Conrad et al. 2011; Heavner, Smallbone et al. 2012). 
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The differences between FBA and limed-FBA can reveal subtle issues with 
existing experimental data. For example, because FBA allows recycling of coenzyme A 
and the biosynthesis of coenzyme A requires pan-2 (Lakin-Thomas and Brody 1985), the 
essentiality of pan-2 is missed by FBA. In contrast, limed-FBA correctly predicts 
essentiality of pan-2. Similarly, three other genes involved in coenzyme A biosynthesis 
(NCU08925 and pan-3) and mitochondrial transport (mic-30) were predicted to be 
essential by limed-FBA, but not by FBA. Surprisingly, these three genes were in our test 
set of non-essentials. A potential explanation for these inconsistencies is that the function 
of these genes can be performed by an isozyme that was not captured in our model. In 
addition to these three genes, there is one more gene from our test set of non-essentials 
where limed-FBA predicted essentiality, but FBA predicted non-essentiality. This gene is 
pab-1. Like arg-14 (Figure 13C), pab-1 serves as input to a metabolic cycle, so pab-1 is 
not required by FBA. However, consistent with limed-FBA’s prediction, the pab-1 gene 
was reported to be essential by Beadle and Tatum’s original publication (Beadle and 
Tatum 1941; Tatum and Beadle 1942). 
In the left panel of Figure 14C, we compared the N. crassa iJDZ836 gene 
essentiality accuracy statistics on the training set to the reported accuracies E. coli and S. 
cerevisiae models that were optimized using experimental observations of gene 
essentiality (Kumar and Maranas 2009; Zomorrodi and Maranas 2010). In the right panel 
of Figure 15C, we compared the N. crassa iJDZ836 gene essentiality accuracy statistics 
on the test set to the accuracy statistics reported in the most recently published models of 
E. coli (Orth, Conrad et al. 2011)  and S. cerevisiae (Heavner, Smallbone et al. 2012). In 
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all cases, the N. crassa iJDZ836 model prediction accuracies compare favorably, 
outperforming the specificities of the extensively trained models for E. coli and S. 
cerevisiae. 
The prediction of gene essentiality for all genes in the model is available in Table 
S2. 
5.2.1 Experimentally observed inviable mutants that were predicted viable 
There were four inconsistencies where the model predicted viability and 
experimental data indicated lethality; these were thi-4, ace-7, and ace-8 in the training 
set, and arg-4 in the test set. The gene thi-4 is required for its role in the thiamin 
diphosphate (TPP) biosynthesis pathway. However, this pathway includes the eukaryotic 
thiazole synthase, and to the best of our knowledge its reaction has not been 
characterized. Thus, this pathway was not included in the model. The incorrect prediction 
of the ace-7 and ace-8 mutants from the training set is likely due to regulatory effects, 
which our model does not capture. ace-7 encodes a subunit of glucose-6-phosphate 
dehydrogenase, and it has been experimentally shown that glucose-6-phosphate 
dehydrogenase tightly controls NADPH regeneration (Brody and Tatum 1966; Scott and 
Tatum 1970; Scott 1971; Nishikawa and Kuwana ; Zhang, Qu et al. 2008). But since the 
model predicts that NADPH can be regenerated by many enzymes, we were unable to 
capture the essentiality of ace-7. The gene ace-8 encodes pyruvate kinase, which is 
known to partially control glycolysis (Thompson and Torchia 1984). Thus, loss of ace-8 
could inhibit glycolysis in vivo, which would be lethal. But since the model predicts that 
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pyruvate kinase’s function can be circumvented by other enzyme activities, the model 
was unable to capture the essentiality of ace-8. 
The only inconsistency in the test set where the model predicted viability was 
arg-4, which encodes acetylornithine-glutamate transacetylase. Upon closer examination, 
it turned out this mutant was experimentally observed to have some growth, albeit very 
little (Srb and Horowitz 1944). The model mechanistically explains viability by 
predicting that loss of acetylornithine-glutamate transacetylase activity can be 
compensated by acetylornithine deacetylase activity encoded by arg-11. Furthermore we 
do predict that the double knockout Δarg-4Δarg-11 is synthetically lethal (see Figure S1). 
5.2.2 Experimentally observed viable mutants that were predicted inviable 
There was only one inconsistency in the training set where the model predicted 
lethality and the experimental data indicated viability, and this prediction revealed an 
error in the underlying experimental data. The experimental phenotyping for the Δerg-14 
knockout indicated growth, and hence we included this gene in the non-essential training 
set. In contrast, the model predicted that the Δerg-14 knockout was blocked in the 
production of mevalonate, which is a necessary precursor for the sterol component of 
biomass. Moreover, previous attempts to phenotype temperature-sensitive mutants of 
erg-14 revealed severe morphological defects that were expected to be lethal in the full 
knockout (Seiler and Plamann 2003). Driven by these inconsistencies, a re-examination 
of the Δerg-14 knockout strain revealed this mutant used was in fact a heterokaryon that 
retained a copy of the erg-14 gene rather than a homokaryon that contained no erg-14 
59 
 
gene, as originally thought. Thus the predictions of the model were sufficient to correct 
an error in metadata associated with a publically available knockout strain. 
We identified 19 inconsistencies in the test set where the model predicted 
inviability and experimental data (Colot, Park et al. 2006) indicated viability. For some of 
these inconsistencies, either the predicted essential function was not required for growth, 
or an unknown gene can perform the same function. For example, five knockouts, Δrg-1, 
Δglp-1, ΔNCU06348 (myo-inositol-1-monophosphotase), Δchi-1, and Δdo, were 
predicted to lack essential cell wall components. Two knockouts, Δmtr and Δmic-18, 
were predicted to lack essential mitochondrial transport of glutamine and 2-oxoglutarate, 
respectively. The Δlys-7  knockout was predicted to lack part of the essential lysine 
biosynthesis pathway (Trupin and Broquist 1965).   
In one case, a candidate isozyme appears likely. The model predicted that ndk-1 
encodes nucleoside diphosphate kinase activity. However, 10-15%  of this activity was 
observed in the Δndk-1 knockout (Lee, Yoshida et al. 2006). Interestingly, nucleoside 
diphosphate kinase activity was also shown to be performed by adenylate kinase in E. 
coli (Lu and Inouye 1996). Since adenylate kinase in Neurospora is encoded by adk-1, 
this gene may encode a moonlight activity that can account for our incorrect prediction.  
Four of the knockout mutants, ΔNCU08925, Δpan-3, Δmic-30 and Δpab-1, were 
incorrectly predicted to be essential according to limed-FBA, but correctly predicted to 
be nonessential by FBA. The reasons for these inconsistencies were described in the main 
text after the discussion of Figure 4B. 
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For the remaining five inconsistencies the problem may be with the test data, 
because, like Δpab-1, other experimental observations of these knockout mutants are 
consistent with our prediction of essentiality. his-1 was reported to be a histidine-
requiring mutant (Ames 1957). trp-4 was reported to be an L-tryptophan-requiring 
mutant (Catcheside 1960; Lester 1963) because it was shown to lack anthranilate 
phosphoribosyltransferase activity (Wegman and DeMoss 1965). pyr-2 was reported to 
be a uracil-requiring mutant (Caroline 1969). pyr-1 was reported to be a uridine-requiring 
mutant (Caroline 1969) because it was shown to lack dihydroorotate dehydrogenase 
activity (Miller 1978). 
5.3 Prediction of nutrient rescue 
To validate the ability of the N. crassa iJDZ836 model to predict nutrient 
supplements that would rescue auxotroph mutants, we manually curated a collection of 
nutrient rescue conditions from the literature. We split this collection into a training set, 
which we used with FARM to construct the model; and an independent test set, which we 
used to validate the final model. Both of these collections are available in Table S1. The 
predictions of nutrient rescues are available in Table S2. To simulate nutrient rescue 
experiments, we took a mutant that was predicted to be inviable on minimal media, 
supplemented the media with different nutrients, and applied limed-FBA to predict 
whether or not the mutant could grow in the supplemented media. We then compared 
experimental observations to the model’s in silico predictions. 
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Of the 77 experimentally observed nutrient rescue conditions that we used as a 
training set, the model correctly predicted 74 (sensitivity=96.1%)(Figure 16A; left panel). 
On the independent test set of 19 nutrient rescue conditions, the model correctly predicted 
17 (sensitivity=89.5%)(Figure 17A; right panel).  
 
Figure 18. Prediction of nutrient rescue.  We curated a collection of conditions in which an auxotroph was 
rescued when minimal media was supplemented with a nutrient. We separated the collection into a training 
set, where knowledge of the rescue phenotype was used to improve the model, and a test set, where the 
rescue phenotype was hidden from the model. Because we only collected data on which nutrients rescued 
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the auxotrophs, we could only measure sensitivity, not specificity. (A) Tables showing the sensitivity of 
limed-FBA predictions on nutrient rescue training and test sets. (B) Heatmap showing the growth 
phenotype of each mutant when minimal media is supplemented with each nutrient used in the training and 
test sets. Only mutants whose minimal media gene essentiality was correctly predicted are included. The 
minimal media used was Vogel’s with sucrose as the carbon source except in the following cases: acu-3,5,6 
genes are essential when acetate is the sole carbon source; oxD  is essential when D-methionine is the sole 
sulfur source; nit-3 is essential when nitrate is the sole nitrogen source. Green squares indicate that the 
model’s predictions were consistent with experiment; red squares indicate that the model failed to correctly 
predict growth; blue squares indicate potentially novel rescues; white squares indicate predictions of non-
rescue. Striped squares show that the multi-substrate case does not contain additional information beyond 
the single-substrate case, e.g. methionine is predicted to rescue the cys-4 mutant, so methionine+threonine 
is also predicted to rescue cys-4. 
 
5.3.1 Experimentally observed nutrient rescues that were not predicted 
In the training set, the only auxotrophs we were unable to correctly rescue were 
due to condition-specific regulation that our model does not capture. According to 
experimental observation, mutants in ace-2, ace-3 and ace-4 can grow in acetate minimal 
media, because the enzymes in the glyoxysome are induced when extracellular acetate is 
present in the medium (Kuwana and Okumura 1979). Conversely, ace-2, ace-3 and ace-4 
mutants cannot grow in sucrose minimal media, even though sucrose can be converted to 
acetate intracellularly, because the glyoxysomal enzymes are not expressed in this 
condition (Davis 2000). Because the acetate-dependent regulation of the glyoxysome is 
not included in our model, we could not successfully predict both their inviability in 
sucrose minimal media and their rescue by acetate supplementation. 
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In the test set, we were unable to correctly rescue ad-5 by hypoxanthine or 
adenine due to large amounts of experimentally observed accumulation of AICAR 
(Bernstein 1961), which neither FBA nor limed-FBA allow. When we relaxed the in 
silico constraint on intracellular accumulation of AICAR, the hypoxanthine and adenine 
rescues of ad-5 were correctly predicted. 
5.4 Mechanistic insight of nutrient rescue 
Simulating the biochemical genetics experiments originally performed on 
Neurospora, we predicted 175 nutrient rescues of 58 auxotroph mutants. These 
predictions are shown in Figure 19B. In addition to predicting the nutrient conditions that 
rescue selected mutants, the model also provides a potential mechanistic explanation for 
the rescue. 
Most of the predictions can be explained by the general principle that 
supplementing a metabolic pathway downstream of a knockout will often rescue the 
mutant, while supplementing the pathway upstream of the knockout typically does not 
(Beadle and Tatum 1941). This is illustrated in Figure 20, where the model correctly 
predicts that cys-5, cys-9, and cys-11 mutants can be rescued when the downstream 
nutrients sulfite and thiosulfate are provided in the media (Murray 1965). Similarly, the 
model correctly predicts that met-2, met-5, met-6, met-7 and met-8 mutants are rescued by 
L-methionine; met-2, met-5 and met-7 mutants are rescued by L-homocysteine; and met-5 
and met-7 mutants are rescued by L-cystathione (Horowitz 1947; Murray 1960). 
64 
 
 
Figure 21. Mechanistic insight into the nutrient rescue of cysteine and methionine metabolism.  The model 
correctly predicts that cys-5, cys-9, and cys-11 mutants can be rescued when the downstream nutrients 
sulfite and thiosulfate are provided in the media. Similarly, the model correctly predicts that met-2, met-5, 
met-6, met7 and met-8 mutants are rescued by L-methionine; met-2, met-5 and met-7 mutants are rescued 
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by L-homocysteine; and met-5 and met-7 mutants are rescued by L-cystathione. The model makes the 
potentially novel predictions that hom-1 and all cys mutants can be rescued by the downstream supplements 
L-cystathione, L-homocysteine and L-methionine. The model also makes the potentially novel prediction 
that cys-4 is not rescued by either upstream nutrient supplements sulfite or thiosulfate. 
This principle provides a testable hypothesis for the novel predictions that hom-1 
and all cys mutants can be rescued by the downstream supplements L-cystathione, L-
homocysteine and L-methionine (see Figure 22). Conversely, we also predict that the cys-
4 mutant is not rescued by either upstream supplements sulfite or thiosulfate. 
Using this principle, Figure 23 shows how the nutrient rescue of acu mutants can 
be explained by examining the connection between the glyoxylate cycle and 
gluconeogenesis. acu-3, acu-5 and acu-6 mutants are known to be lethal when acetate is 
the sole carbon source, because the glyoxylate cycle is blocked (Beever and Fincham 
1973). We correctly predict these mutants can be rescued by sucrose (Flavell and 
Fincham 1968), and we additionally predict they can be rescued when supplemented with 
fructofuranose and glucose, because the enzymes encoded by acu-3, acu-5, and acu-6 are 
upstream of these sugars in the gluconeogenesis pathway. 
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Figure 24. Connection between glyoxylate cycle and gluconeogenesis reveals mechanistic insight into the nutrient 
rescue of acu mutants.  acu-3, acu-5 and acu-6 mutants are known to be lethal when acetate is the sole 
carbon source, because the glyoxylate cycle is blocked (Beever and Fincham 1973). We correctly predict 
these mutants can be rescued by sucrose, and we additionally predict they can be rescued when 
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supplemented with fructofuranose and glucose, because the enzymes encoded by acu-3, acu-5, and acu-6 
are upstream of these sugars in the gluconeogenesis pathway. 
Some novel nutrient rescue predictions can be explained by the existence of an 
alternate pathway from the nutrient to an essential metabolite that could not otherwise be 
produced. For example, Figure 25 shows that the ace-2, ace-3, and ace-4 gene products 
are all components of the pyruvate dehydrogenase complex, which synthesizes acetyl-
CoA from pyruvate, and that this activity leads to the production of the essential 
metabolite 2-oxoglutarate (α-ketoglutarate) via the TCA cycle. The model also predicts 
that ace-2,3,4 mutants can be rescued by L-citrulline, L-arginine, L-ornithine, and L-
glutamine, because each of these nutrients can produce 2-oxoglutarate via amino acid 
degradation pathways. 
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Figure 26. Supplementing with nutrients in alternate pathways can rescue some mutants.  The model makes the 
novel prediction that ace-2, ace-3, and ace-4 mutants (purple) in the TCA cycle can be rescued by 
supplementing minimal media with L-citrulline, L-arginine, L-ornithine, or L-glutamine (light blue) 
because each of these nutrients provide an alternate route via amino acid pathways to the essential 
metabolite 2-oxoglutarate (red). 
5.5 Prediction of synthetic lethal interactions 
Pairwise synthetic lethality arises when two mutants with single gene knockouts 
are viable, but the double knockout mutant is inviable. Synthetic lethality can reveal 
cross-pathway dependencies that provide valuable insights into metabolism at the 
genome scale, but an experimental approach to comprehensively perform double 
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knockouts to identify synthetic lethals is currently infeasible for Neurospora. 
Computational models provide a mechanism to rapidly and comprehensively test all 
interactions as a way to prioritize subsequent experimental verification. To predict 
synthetic lethality using the model, we simulated all pairs of knockouts of non-essential 
genes and predicted viability on minimal media. 
Of the roughly 700,000 double knockouts in the metabolic model, the model 
predicted 230 to be synthetically lethal on minimal media. The mechanisms underlying 
these predicted synthetic lethal interactions fall into three classes: those that encode 
isozymes of a common reaction, those that encode enzymes of a common pathway, and 
those that encode enzymes of interacting pathways. This list contains 22 isozyme pairs, 4 
gene pairs in the same pathway, and 204 gene pairs in interacting pathways. All of these 
pairs are tabulated in Table S2. The non-isozyme gene pairs and a previously known 
isozyme pair are displayed in a symmetric interaction map in Figure 27. This interaction 
map classifies each synthetic lethal pair by whether or not the two genes are in a common 
pathway or interacting pathways. 
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Figure 28. Synthetic lethality interaction map.  This gene-by-gene interaction map shows synthetic lethal 
predictions on Vogel’s minimal media, except the double mutant pyr-1:uc-5 is on Vogel’s+uracil. Shown 
are non-isozyme pairs, except the previously known isozyme pair cys-13:cys-14. If both synthetic lethal 
genes of a pair are in a common pathway, the square is cyan; if they are in interacting pathways, then it is 
colored orange. Validated synthetic lethal predictions have a black border. 
5.6 Mechanistic insight of synthetic lethal interactions 
To validate the ability of the model to predict synthetic lethality, we manually 
curated a small number of experimentally observed synthetic lethal interactions. Some of 
these interactions involved the arg-2 mutant, which is known to be "leaky" (Davis 1979). 
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We used the remaining synthetic lethal interactions to validate our results. Of these 5 
experimentally observed synthetic lethal interactions, the model correctly predicts 4. 
The single known interaction not predicted by the model is for the double mutant 
pho-4:pho-5 (Versaw 1995). Both of these genes are high-affinity phosphate transporters, 
but the model also includes a known low-affinity phosphate transporter. The model treats 
each of these transporters equally, because it lacks kinetics, so it predicts the pho-4:pho-5 
mutant is viable. 
Figure 29 shows three known synthetic lethal interactions that we correctly 
predict. Figure 30A provides an example of synthetic lethality arising from mutations in a 
common pathway. The nitrogen assimilation pathway fixes the nutrient nitrate into the 
essential metabolite glutamine. Both the am and en(am)-2 mutants are viable, because 
they represent the two alternate routes to synthesize glutamine. However, the double 
mutant am:en(am)-2 is blocked in both routes, so it is inviable, unless the nutrient media 
is supplemented with glutamate.  
Figure 31B provides an example of synthetic lethality arising from mutations in 
two interacting pathways. The pathways for proline biosynthesis and arginine 
degradation both synthesize glutamate-semialdehyde, which is a precursor to the essential 
metabolite L-proline. Both the pro-3 (glutamate-5-semialdehyde dehydrogenase) mutant 
in proline biosynthesis, and the ota (acetylornithine transaminase) mutant in arginine 
degradation are viable, because they represent the two alternate routes to synthesize L-
proline. However, the double mutant pro-3:ota is blocked in both routes, so it is inviable, 
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unless the nutrient media is supplemented with L-proline. 
Figure 32C provides another example of synthetic lethality arising from two 
interacting pathways. On uracil-containing media, the uridine-5’-phosphate synthesis 
pathway and the path from uracil to uridine-5’-phosphate (UMP) both synthesize the 
essential UMP. So on uracil-containing media, both pyr-1 (dihydroorotate 
dehydrogenase) in uridine-5’-phosphate synthesis and uc-5 (uracil permease) are viable, 
because they represent the two alternate routes to synthesize UMP. Consequently, the 
double mutant pyr-1:uc-5 on uracil-containing media is blocked in both routes, so it is 
inviable. Further, the pyr-1:uc-5 mutant can be rescued by uridine, since uridine can be 
phosphorylated to UMP. 
 
Figure 33. Mechanistic insight into three experimentally validated synthetic lethal auxotrophs and their nutrient 
rescue.  (A) The nitrogen assimilation pathway contains two alternate routes that convert α-ketoglutarate 
into the essential metabolite L-glutamine (red). (A1) The en(am)-2 mutant is viable, because α-
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ketoglutarate can be aminated to L-glutamate via am. (A2) The am mutant is viable, because α-
ketoglutarate and L-glutamine can be converted to 2 L-glutamate via en(am)-2. (A3) The double mutant 
am:en(am)-2 is lethal when ammonium is the nitrogen source because both routes to L-glutamine are 
blocked, but (A4) can be rescued when the media is supplemented with L-glutamate (A4). (B) The only 
two routes for the synthesis of the essential metabolite L-proline are through arginine degradation and 
proline biosynthesis. (B1) The pro-3 mutant is blocked in proline biosynthesis, but can obtain L-proline 
through arginine degradation. (B2) The ota mutant is blocked in arginine degradation, but can obtain L-
proline through proline biosynthesis. (B3) The double mutant pro-3:ota is blocked in both routes, but can 
be rescued when the nutrient media is supplemented with L-proline (B4). (C) There are only two 
biosynthetic routes to the essential metabolite uridine-5’-phosphate. (C1) The pyr-1 mutant can still obtain 
uridine-5’-phosphate from extracellular uracil, and the uc-5 mutant can obtain uridine-5’-phosphate from 
(S)-dihydroorotate (C2), but the pyr-1:uc-5 double mutant is blocked in both routes (C3). However, it can 
be rescued when the nutrient media is supplemented with uridine through its conversion to uridine-5’-
phosphate in the pyrimidine salvage pathways (C4). Side compounds not shown. 
The novel predictions of synthetic lethality provide testable hypotheses for further 
experimentation. For example, the model predicts synthetic lethality between NCU02726 
(ethanolamine kinase) and gsl-3 (3-dehydrosphinganine reductase). The products of these 
two genes catalyze reactions in two different pathways that lead to the production of the 
essential metabolite phosphoryl-ethanolamine. Ethanolamine kinase converts 
ethanolamine to phosphoryl-ethanolamine in a single reaction. Without ethanolamine 
kinase, the model predicts that phosphoryl-ethanolamine must be produced from the 
sphingolipid metabolism pathway. This requires the activity of gsl-3, which is an 
upstream member of this pathway. 
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Figure S2 illustrates the potential mechanism underlying the predicted synthetic 
lethality between the suc gene (pyruvate carboxylase) and subunits of mitochondrial 
complex I (NADH:ubiquinone oxidoreductase). Under normal circumstances, NADH 
produced in the mitochondrial TCA cycle is oxidized to NAD in the electron transport 
chain via NADH:ubiquinone oxidoreductase. Yet, the loss of complex I is known to be 
non-lethal in Neurospora (Videira 1998). This places a metabolic burden on the rest of 
mitochondrial metabolism to oxidize the NADH. The model predicts that in the absence 
of complex I, NADH is oxidized by malate dehydrogenase in the reverse direction of the 
normal TCA cycle flux. To maintain this flux, the mitochondrion requires a steady source 
of oxaloacetate, which can only be supplied from pyruvate carboxylase, encoded by suc. 
This synthetic interaction is particularly noteworthy, because S. cerevisiae lacks complex 
I, making Neurospora a prime model for studying its interactions.  
5.7 Methods 
5.7.1 Metabolic reconstruction protocol 
The metabolic reconstruction of Neurospora crassa was performed in accordance 
with previously described protocols (Thiele and Palsson ; Segre, Zucker et al. 2003), and 
is detailed in Text S2. 
5.7.2 Creation and curation of NeurosporaCyc 
From the Neurospora crassa genome assembly NC10, gene boundaries were 
predicted using the Calhoun annotation system (Galagan, Calvo et al. 2003). For all 
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enzymes, we obtained the probability that the enzyme catalyzes a particular biochemical 
reaction, characterized by its Enzyme Commission (EC) number, from  the enzyme 
function prediction software EFICAz (Arakaki, Huang et al. 2009). 
We used the Pathway Tools software suite (Karp, Paley et al. 2010) to create  the 
NeurosporaCyc Pathway/Genome Database (PGDB) and to manage curated data. We 
added functional gene annotations with associated Gene Ontology (GO) terms 
(Ashburner, Ball et al. 2000) and literature citations that were manually curated by the 
Community Annotation Project (Dunlap, Borkovich et al. 2007). EC numbers, GO terms, 
and functional annotations were used as input to Pathologic (Dale, Popescu et al. 2010) to 
automatically infer pathways from MetaCyc. These pathways comprised the initial 
NeurosporaCyc PGDB. Reaction directions were based on the Gibbs free energy 
predictions using the group contribution method (Jankowski, Henry et al. 2008). Enzyme 
complexes were manually curated using the Pathway Tools protein complex editor and 
evidence from the Neurospora literature (Karp, Paley et al. 2010). Transporters were 
automatically predicted from the genome sequence by the Transporter Automatic 
Annotation Pipeline (TransAAP) from TransportDB (Ren, Chen et al. 2007), and from 
the genome annotation using the Transport Identification Parser (TIP) (Lee, Paulsen et al. 
2008). Cellular compartment information was described using the Cellular Component 
Ontology (CCO), available at http://bioinformatics.ai.sri.com/CCO/. Neurospora-specific 
enzyme kinetics, allosteric regulation, biomass composition, and growth media were 
added during manual curation of the experimental evidence in the literature. 
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Before the NeurosporaCyc PGDB could be used to generate a working model, a 
number of data-cleaning steps were performed. Reactions were mass balanced, and the 
individual metabolites were protonated to the intracellular pH of 7.2 (Legerton, Kanamori 
et al. 1983). For reactions containing compound classes (e.g. “an alcohol”), the 
compound class was replaced by its instances (e.g. “ethanol”) that render the equation 
mass-balanced. Polymerization pathways such as fatty acid beta oxidation were either 
lumped into a summary reaction, or instantiated into a chain of individual polymerization 
steps. For polymerization reactions, we specified an arbitrary maximum polymer size n 
and created a lumped reaction that was stoichiometrically equivalent to n steps of the 
polymerization. The NeurosporaCyc Pathway/Genome Database can be downloaded 
from the PGDB registry at http://biocyc.org/registry.html and is available online at 
http://neurosporacyc.broadinstitute.org. 
5.7.3 Curation of growth rate data 
To curate our growth rate data, we identified several manuscripts that included 
glucose concentrations for Neurospora grown on glucose minimal medium where 
doubling times could be inferred from growth curves (Neville, Subkind et al. 1971) or 
were given (Schneider and Wiley 1971; Courtright 1975). The glucose concentrations 
were converted to glucose uptake rates using data for the derepressed system in Figure 1 
of Schneider and Wiley (Schneider and Wiley 1971). 
5.7.4 Curation of viability phenotype data 
To curate our viability phenotype data, we primarily relied on two resources. The 
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first was The Neurospora crassa e-Compendium, curated by Alan Radford. The e-
Compendium contains >2,400 citations and >3,000 gene entries. Numerous gene entries 
have associated mutant phenotypes extracted from the literature. In some cases, these 
phenotypes also include supplements that rescue no-growth mutants. Because this 
resource primarily lists phenotypes from mutants that are not knockouts, viability of a 
mutant could be due to non-essentiality of a mutated gene or to partial efficacy of a 
mutated enzyme. Thus, this resource did not clearly identify non-essential genes. The 
second resource was knockouts from the Neurospora Genome Project (Dunlap, 
Borkovich et al. 2007). Knockouts that did not germinate and grow in a short time were 
not further evaluated to determine whether they showed low growth or no growth, so this 
project did not clearly identify essential genes. 
To collect the essential gene sets, we first identified inviable mutants in the e-
Compendium, and only retained genes for which we could manually verify their 
essentiality in the literature. To split the essential genes into a training set and a test set 
we intersected the list of inviable mutants in the e-Compendium with the list of 
heterokaryon knockouts from the Neurospora Genome Project 
(http://www.dartmouth.edu/~neurosporagenome/knockouts_completed.html). Genes that 
were in the intersection became the test set, and the rest remained in the training set. 
To collect the non-essential gene sets, we used the homokaryon knockouts from 
the Neurospora Genome Project (Colot, Park et al. 2006), all of which were 
experimentally observed to be viable in Vogel’s minimal media (Alberghina 1973). A 
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subset of these homokaryons was extensively phenotyped, and these were available at the 
Neurospora crassa Database at the Broad Institute 
(http://www.broadinstitute.org/annotation/genome/neurospora/Phenotypes.html). This 
subset became our non-essential training set, while the rest of the homokaryon knockouts 
became our non-essential test set. Homokaryon knockouts that were in the essential gene 
set were discarded. 
Both the supplemental nutrient rescue training and test sets were initially 
identified from the e-Compendium and from the book Neurospora: Contributions of a 
Model Organism (Davis 2000). They were then confirmed through manual curation of 
the associated citations. We also used this protocol to identify and confirm known 
synthetic lethal mutations. 
5.7.5 Comparison of experimental to predicted phenotype data 
We simulated Vogel’s minimal media (http://www.fgsc.net/methods/vogels.html) 
(McCluskey, Wiest et al. 2010) with sucrose by including exchange reactions for each 
metabolite in the media, and limiting sucrose uptake to 1.5 mmol/(gram Dry Weight * 
hour). Alternative media were formulated in silico by adding/removing exchange 
reactions. Supplemental nutrients were limited to a flux of 3 mmol/(gram Dry Weight * 
hour).  
We simulated gene knockouts by removing reactions that require knocked-out 
genes. Biomass flux was predicted using limed-FBA, except where stated otherwise. In 
silico growth phenotypes were regarded as viable if the biomass flux exceeded 0.02, and 
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inviable otherwise. FBA was run using the optimizeCbModel function from the COBRA 
Toolbox 2.0.5 (Becker, Feist et al. 2007) using Gurobi 5.0 in Matlab (MathWorks, 
Natick, MA). MD-FBA was run using Matlab code downloaded from Tomer Shlomi’s 
Research Group’s website (http://www.cs.technion.ac.il/~tomersh/methods.html) with 
Tomlab v7.9 and CPLEX 12.2. This code was modified for our model: all MD-FBA 
constraints could be satisfied by wild-type on Vogel’s minimal media, so we did not need 
to apply their addNewExReactions function. This code allowed 400 seconds per 
optimization. 
5.7.6 Creation of COBRA-compatible SBML model 
We exported the model to the COBRA-compatible subset of the Systems Biology 
Markup Language (SBML) (Hucka, Finney et al. 2003; Schellenberger, Que et al. 2011). 
All SBML identifiers were based on NeurosporaCyc Frame IDs. To avoid using 
characters disallowed in SBML identifiers, we implemented a substitution scheme. We 
substituted disallowed characters with their ASCII equivalent, demarcated on both sides 
by two underscores. For example, "[" has ASCII value 91, so it was substituted by 
"__91__". Identifiers beginning with a number were given a prefix of underscore; e.g. 
"1diacyl" became "_1diacyl". So that our SBML file can be reversed-transformed into its 
original character encoding, we wrote an extension to the COBRA toolbox in Matlab. 
This extension is available at http://code.google.com/p/fast-automated-recon-metabolism. 
SBML Notes fields contain COBRA-compliant gene associations, pathways, EC 
numbers, Pubmed IDs, chemical formulae, charge, and NeurosporaCyc and KEGG 
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identifiers (Schellenberger, Que et al. 2011). SBML Annotation fields contain MIRIAM-
compliant links to InChI identifiers (Le Novere, Finney et al. 2005; Heller, McNaught et 
al. 2013). 
5.7.7 Model availability 
The metabolic model has been deposited at the BioModels Database (Li, 
Donizelli et al. 2010) with accession MODEL1212060001, and is available on the web at 
http://neurosporacyc.broadinstitute.org. 
5.8 Reconstruction protocol 
Here, we compare our reconstruction to the protocol from Thiele and Palsson 
(Thiele and Palsson 2010). 
5.8.1 Stage 1: Creating a draft reconstruction 
1 Obtain genome annotation 
During the reconstruction process, the Neurospora crassa genome sequence has 
undergone numerous genome assemblies and gene sets. We mapped all genes in the 
model to the most recent release at the time of submission (assembly 10 gene set v5). 
2 Identify candidate metabolic functions 
Enzyme commission (EC) numbers were inferred from protein sequence using EFICAz2 
(Tian and Skolnick 2003; Tian, Arakaki et al. 2004; Arakaki, Tian et al. 2006; Arakaki, 
Huang et al. 2009). 
3 Obtain candidate metabolic reactions for these functions 
Reactions associated with EC number predictions and reactions inferred from 
81 
 
pathway predictions were imported from MetaCyc using Pathologic (Karp, Paley et al. 
2002; Green and Karp 2004; Lee, Paulsen et al. 2008; Latendresse, Krummenacker et al. 
2012). 
4 Assemble draft reconstruction 
Draft reconstruction was assembled into NeurosporaCyc Pathway/Genome 
Database (PDGB). 
5 Collect experimental data 
Experimental evidence for enzyme activities was curated from the Neurospora 
Community Annotation Project (Dunlap, Borkovich et al. 2007). 
5.8.2 Stage 2: Manual reconstruction refinement 
6 Determine and verify substrate and cofactor usage 
Substrates and cofactors for reactions were determined as follows: 
• non-generic reactions were imported directly from MetaCyc into 
NeurosporaCyc 
• generic EC numbers were instantiated by generating all instances of generic 
substrates and filtering out unbalanced reactions using an extension of the 
code described in (Latendresse, Krummenacker et al. 2012). 
• polymerization reactions were lumped into a single reaction that summarizes 
the stoichiometry of n iterations of polymerization, where n was arbitrarily set 
to 8. 
7 Obtain a neutral formula for each metabolite in the reaction 
Neutral formulas were obtained using MarvinBeans major microspecies at pH 7.0 
8 Determine the charged formula for each metabolite in the reaction. 
Charged formulas were obtained using MarvinBeans major microspecies at pH 
7.2 (Legerton, Kanamori et al. 1983) for the cytoplasm, and pH 6.8 for the vacuole. 
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9 Calculate reaction stoichiometry. 
Reaction stoichiometries for charged formulae were calculated using the 
Pathway-tools reaction balancer code (Latendresse, Krummenacker et al. 2012). 
10 Determine reaction directionality 
Reaction directionality was computed from the Gibbs free energy using the group 
contribution method (Jankowski, Henry et al. 2008). 
11 Add information for gene and reaction localization 
Gene locations were obtained from the Neurospora Community annotation project 
gene ontology terms (Dunlap, Borkovich et al. 2007). Reaction locations were curated 
from the literature (Davis 2000). 
12 Add subsystem information to the reaction 
Pathways (subsystems) were computed using Pathologic (Karp, Paley et al. 2002). 
13 Verify GPR association 
Gene-reaction associations were computed using EFICAz, followed by enzymes 
identified by the Pathway hole filling algorithm (Green and Karp 2004; Arakaki, Huang 
et al. 2009). Enzyme complexes were semi-automatically constructed using the Pathway-
tools protein-complex building tool followed by manual curation (Karp, Paley et al. 
2002). 
14 Add metabolite identifier 
SMILES and InChI’s were computed from the chemical structure of the charged 
compounds in NeurosporaCyc. External references to equivalent KEGG, Pubchem, and 
ChEBI identifiers were also exported, when available. 
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15 Determine and add the confidence score 
Confidence scores per reaction were based on the following types of evidence: 
a EFICAz precision probability 
b Is enzyme in a curated pathway? 
c Does enzyme have experimental evidence from literature citations? 
d Is reaction predicted to be in NeurosporaCyc by Pathologic based on pathway 
holes? 
16 Flag those reactions for which information from other organisms was used 
Enzyme functions inferred using sequence homology were marked as such using 
the Pathway-tools evidence ontology (Karp, Paley et al. 2004) 
17 Add references and notes based on experimental information 
For enzyme functions supported by literature citations, we also included an 
evidence code using the Pathway-tools evidence ontology (Karp, Paley et al. 2004) 
18 Repeat Steps 6–17 for all those genes that were identified in the draft 
reconstruction 
19 Add spontaneous reactions to the reconstruction 
Spontaneous reactions were added from MetaCyc. 
20 Add extracellular and periplasmic transport reactions to the reconstruction 
Transport reactions were based on manual curation of the automated transport 
predictions (Lee, Paulsen et al. 2008). Extracellular reactions were based on evidence 
from literature citations. 
21 Add exchange reactions to the reconstruction 
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Exchange reactions were added for all nutrients in the media. 
22 Add intracellular transport reactions to the reconstruction 
Intracellular transport reactions were added based on evidence from literature 
citations. Cell components were categorized according to Pathway-tools extension of the 
Cell Component Ontology (http://bioinformatics.ai.sri.com/CCO) (Ashburner, Ball et al. 
2000). 
23 Draw metabolic map 
An initial draft of the metabolic map was automatically generated using the 
NeurosporaCyc cellular overview (Latendresse, Krummenacker et al. 2012). Further 
work on the map was done in Adobe Illustrator. 
24 Determine the chemical composition of the cell, i.e., protein, RNA, DNA, lipids, 
and cofactor content 
Biomass was decomposed into separate synthesis reactions for DNA, RNA, 
amino acids, carbohydrates, lipids, sterols, essential cofactors, growth-associated ATP 
maintenance, and secondary metabolites. This decomposition allows for modular 
construction of biomass objective functions depending on the goals of the FBA. For 
example, to predict wild-type fluxes we compiled all of these elements into full biomass 
composition. Wild-type biomass contains substantial secondary metabolites, such as 
carotenoids (which give Neurospora its color), sphingolipids, and ergosterol, but mutants 
that do not contain these do (slowly) grow. Consequently, to predict gene essentiality we 
removed these secondary metabolites to form essential biomass composition. 
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25 Determine the amino acid content either experimentally (option A) or by 
estimation (option B) 
Amino acid composition was estimated from parsing Neurospora Uniprot's amino 
acid FASTA file (option B). 
26 The molar percentage and molecular weight of each amino acid must be used to 
calculate the weight per mol protein 
For each amino acid, the total number of times each amino acid appears in the 
Uniprot file was computed. This number was divided by the total number of amino acids 
to compute the Mol fraction (mol AA/ mol protein). This number was multiplied by the 
molecular weight (g AA/mol AA) of the amino acid to derive the g AA/mol protein. We 
then divide the Mole fraction by g AA/mol protein *1000 to obtain the mmol AA/g 
protein. This is used as the stoichiometric coefficient. 
27 Determine the nucleotide content either experimentally (option A) or by 
estimation (option B) 
DNA content was estimated from the number of A/C/G/T in the genome 
(including mitochondrial and chromosomal). RNA content was estimated from the Broad 
Institute Neurospora “transcripts” file. Expression for each gene was assumed to be 
equal. 
28 Calculate the fractional distribution of each nucleotide to the biomass 
composition by repeating Step 26 
29 Determine the lipid content 
Lipid content was divided into glycerophospholipid composition and 
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triacylglyceride (TAG) composition. Glycerophospholipid composition is composed of 
an L-1-phosphatidyl-ethanolamine, a phosphatidylcholine, an L-1-phosphatidylserine, 
and an L-1-phosphatidyl-inositol. The fatty acid stoichiometric composition of 
phospholipids on minimal media were derived from figure 1C of (McKeon, Goodrich-
Tanrikulu et al. 1997). The headgroup stoichiometric composition was derived from table 
6.4 of (Davis 2000). Since there are two acyl groups per phosphoglycerol, we double 
fatty acid composition (which adds up to 1) to get the correct stoichiometry. Fatty acid 
stoichiometric coefficients for TAGs under minimal medium were derived from Figure 
1C in (McKeon, Goodrich-Tanrikulu et al. 1997). Since there are three acyl groups per 
triacylglycerol, we tripled the fatty-acid composition (which added up to 1). 
30 Determine the content of the soluble pool 
The soluble pool of metabolites such as NAD, thioredoxin, ferredoxin, and 
glutathione was not added to the biomass, because limed-FBA already requires the 
biosynthesis of cofactors and vitamins required for growth. However, we found that even 
with limed-FBA we needed to include the reaction FADH2   FAD to recapitulate gene 
essentiality data. 
31 Determine the ion content 
Ion content was not determined for this release of the model. 
32 Determine growth-associated maintenance (GAM) stoichiometric ratio 
We identified a GAM ratio that provided the best fit to experimentally observed 
growth rates on Vogel’s minimal media with glucose. 
33 Compile and add biomass reaction to the reconstruction 
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See step 24 above. 
34 Add non-growth-associated maintenance (NGAM) requirements of the cell to 
maintain turgor pressure and other non-metabolic cellular processes 
The lower bound for this reaction was taken from A. niger, where it was estimated 
from growth experiments in continuous culture (Andersen, Nielsen et al. 2008). 
35 Add demand reactions to the reconstruction 
SecondaryMetaboliteComposition contains non-essential compounds known to be 
produced by Neurospora. 
36 Add sink reactions to the reconstruction 
Our final model does not contain sink reactions. To deal with protein substrates of 
reactions, such as thioredoxin, we created reversible reactions of the form amino acids   
thioredoxin. 
37 Determine growth medium requirements 
Vogel’s Medium N is used almost universally for vegetative growth and stock 
culture (Davis 2000).  Although citrate is in the nutrient media, citrate is not permeable to 
Neurospora, so it cannot serve as an exchange metabolite. 
 
5.8.3 Stage 3: Conversion from reconstruction to mathematical model 
Our reconstruction was stored in the NeurosporaCyc Pathway/Genome database, 
which interacts with the Pathway-tools software (Karp, Paley et al. 2010). Pathway-tools 
is written in the LISP programming language. Thus, we wrote custom tools in LISP to 
convert to a mathematical model. This conversion instantiated NeurosporaCyc's generic 
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reactions, and transferred NeurosporaCyc into text files. These files contained the 
stoichiometric matrix; notes and additional evidence about each reaction; metabolites and 
external references to database independent and dependent identifiers; gene protein 
reaction associations; reactions that were flagged, with a reason for the flag; nutrient 
media; pathways for the reactions; and the subset of reactions (with direction) that 
defined the model. Finally, to communicate our model to the systems biology 
community, we used python to generate an SBML model from these files.   
38 Load nc10.xml reconstruction into Matlab 
39 Verify S matrix 
40 Set objective function 
41 Set objective function 
42 Set simulation constraints 
We then validated the SBML in Matlab, using the Cobra Toolbox. All code has 
been made available at: http://code.google.com/p/fast-automated-recon-metabolism. 
5.8.4 Stage 4: Network evaluation = ‘Debugging mode’ 
43 Test if the network is mass and charge balanced. Check for stoichiometrically 
unbalanced reactions 
44 Evaluate stoichiometrically unbalanced reactions 
45 Identify metabolic dead ends 
46 Identify candidate reactions to fill gaps 
47 Add gap reactions to the reconstruction 
48 Add notes and references to dead-end metabolites 
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49 Add missing exchange reactions to model 
50 Set exchange constraints for a simulation condition 
Network debugging was performed during the phenotype-directed curation phase 
of our model reconstruction process. Gaps, missing exchange reactions, and candidate 
reactions to fill the gaps were all identified by FARM. 
Test for stoichiometrically balanced cycles or Type III pathways 
51 Test for Type III pathways 
52 Analyze the output if Type III pathways are found 
53 Identify Type III pathways 
54 Analyze directionality of each reaction participating in a Type III pathway 
55 Analyze if any reaction participating in a Type III pathway may be falsely 
included in the reconstruction by reviewing the supporting evidence 
56 If none of the reactions or reaction directions can be corrected based on 
experimental or thermodynamic information, you can try to iteratively limit the 
directionality of the loop reactions 
57 Adjust the directionality for all those reactions identified in Steps 54–56, note the 
change and reasons 
58 After eliminating a reaction direction or a deletion of a reaction, repeat the Type 
III pathway analysis 
59 Recompute gap list 
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limed-FBA disallows flux cycles that lack an input flux, so we this eliminates most type 
III pathways, so we did not need to manually adjust the reaction directionality of the 
model to prevent these cycles from occuring. 
Test if biomass precursors can be produced in standard medium 
60 Obtain the list of biomass components 
61 Add demand function for each biomass precursor 
62 For each biomass component, perform the following test: Change objective 
function to the demand function  
63 Maximize ('max') for new objective function  
64 Identify reactions that are mainly responsible for synthesizing the biomass 
component 
65 For each of these reactions, follow the wire diagram given in Figure 14 
Steps 60-65 were tested using dung-FBA, which is a goal programming approach 
discussed in the CROP Supplement. dung-FBA allowed us to test for all biomass 
components simultaneously, and see which ones could be produced and which could not 
66 Test if biomass precursors can be produced in other growth media 
We tested that growth could be achieved in other media known to support Neurospora's 
growth, such as using acetate as a sole carbon source. 
Test if the model can produce known secretion products 
67 Collect a list of known secretion products and medium conditions. 
No secretion products were found 
68 Set the constraints to the desired medium condition 
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69 Change the objective function to the exchange reaction of your secretion product: 
70 Maximize ('max') for the new objective function  
Secretion products for Neurospora are not known. 
Test if the model can produce a certain ratio of two secretion products 
71 Set the constraints to the desired medium condition 
72 Verify that both by-products can be produced independently 
73 Add a row to the S matrix to couple the by-product secretion reactions 
74 Change the objective function to the exchange reaction of one of your secretion 
products 
75 Maximize for the new objective function  
Secretion products for Neurospora are not known. 
Check for blocked reactions 
76 Change simulation conditions to rich medium 
77 Run analysis for blocked reactions 
78 Connect reaction to remaining network 
Blocked reactions were identified and removed using OnePrune. 
Compute single-gene deletion phenotypes 
79 Compute single-gene deletion phenotypes 
80 Compare with experimental data 
We used CROP to compare our single-gene deletion phenotype predictions with 
experimental data to improve the model. 
Test for known incapabilities of the organism 
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81 Set simulation condition 
82 Use single-reaction deletion to identify candidate reactions that enable the 
model's capability despite known incapability 
We used CROP to improve our model using known incapabilities of the organism 
under different nutrient conditions. 
Test if the model can predict the correct growth rate or other quantitative properties 
83 Compare the predicted physiological properties with the known properties 
We do not know Neuropora's nutrient uptake rates, so we cannot accurately gauge 
its growth rate given uptake. However, our predicted growth rate is consistent with 
observed growth rate in Vogel’s medium, when we limit sucrose uptake to 5 mmol/(g * 
hr). 
Test if the model can grow fast enough 
84 Optimize for biomass in different medium conditions and compare with 
experimental data  
85 Test if any of the medium components are growth limiting. 
86 Maximize for biomass 
87 Determine the reduced cost associated with network reactions when optimizing 
for objective function 
We were unable to obtain nutrient uptake rates in order to determine if our growth 
rate was fast enough. 
Test if the model grows too fast 
88 Optimize for biomass reaction in different medium conditions and compare with 
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experimental data 
89 Verify that the model constraints are set as intended 
We were unable to obtain nutrient uptake rates in order to determine if our growth 
rate was too fast. 
Carry out one or more of the following tests to identify possible errors in the network 
90 Verify that all fractions and precursors in the biomass reaction are consistent 
with the present knowledge 
91 Identify shuttling reactions 
92 Re-investigate the thermodynamic information associated with the network 
reaction 
93 Use single-reaction deletion to identify single reactions that may enable the 
model to grow too fast 
94 Reduced cost 
We verified that all fractions and precursors of biomass are consistent with the 
literature.  Citations for each biomass precursor are listed on the associated 
NeurosporaCyc web pages. 
Data assembly and dissemination 
95 Print Matlab model content 
96 Add gap information to the reconstruction output 
In addition to our SBML, associated information is available from our structured 
database NeurosporaCyc, at http://neurosporacyc.broadinstitute.org. 
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6 Discussion 
6.1 Prospects for future work 
The algorithms that comprise FARM can be applied to other cases beyond those 
mentioned here. 
limed-FBA can be applied to other metabolic networks to determine which genes, 
or sets of genes, may be essential. This application should provide essential genes that 
were missed by FBA, as occurred in our model of N. crassa. A caveat to this is that many 
current models were not built to support metabolite dilution, so limed-FBA would predict 
no growth for these models. An important consequence of this fact is that limed-FBA 
could help improve current models, so that they account for the physiological 
phenomenon of growth-associated metabolite dilution. 
CROP can be applied not only to reconstruct metabolic networks of existing 
organisms, but like previous algorithms such as OptStrain (Pharkya, Burgard et al. 2004) 
it can also be used to construct synthetic pathways for production of valuable chemicals.  
To test the ability of CROP to design synthetic pathways, we applied CROP to an 
example worked out by a group at UCLA led by James Liao (Atsumi, Hanai et al. 2008). 
There, they engineered E. coli to produce higher alcohols including isobutanol, 1-butanol, 
2-methyl-1-butanol, 3-methyl-1-butanol, and 2-phenylethanol from glucose. These 
alcohols are not natively produced in E. coli, so they had to begin by inserting the 
necessary genes into E. coli. To simulate this insertion, we began with an E. coli 
metabolic model, and applied CROP by minimizing the number of reactions needed to 
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produce the alcohols. We found that only two enzymes needed to be added: a 2-keto-acid 
decarboxylase (KDC) to convert 2-keto acids to aldehydes, and an alcohol dehydrogenase 
(ADH) to convert the aldehyde to an alcohol. In fact, this was the strategy employed by 
Liao’s group.  
OnePrune can be applied to identify blocked reactions in a variety of metabolic 
networks. For example, it can be used along with limed-FBA to infer which reactions are 
blocked in a model that doesn’t support metabolite dilution. Furthermore, the dual 
variables (or shadow prices) in OnePrune can be informative. The values of these suggest 
the expected number of reactions that would be unblocked by altering the right-hand side 
value by one. (The dual variables are only approximations to this, because they apply to 
infinitesimal changes in the right-hand side value.) 
6.2 Concluding remarks 
Building on its long history as a genetic model organism for biochemical genetics 
and cellular metabolism, we report here the first genome-scale metabolic network model 
for Neurospora crassa. We assessed the Neurospora metabolic model’s ability to predict 
the impact of gene deletions, nutrient supplements that would rescue essential gene 
deletions, and synthetic lethal interactions. In each case, computational predictions were 
validated against a curated dataset of experimentally observed mutant viability 
phenotypes. Importantly, to ensure that our model was not over-fit, we separated the 
experimental data into a training and test set. Whereas training data was used in the 
development of the model, the test set was reserved to assess the accuracy of the final 
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model. The final accuracy assessment was thus independent of any data used during 
model training.  
The prediction of the growth phenotype of gene deletions is a canonical test of 
metabolic model accuracy and a useful benchmark for assessing the quality of different 
models (Becker and Palsson 2008). The accuracy of our model compares favorably to 
extensively curated models such as S. cerevisiae and E. coli. Moreover, at 93% 
sensitivity and specificity on a test set of 303 phenotyped gene knockouts, the 
Neurospora model displays high absolute accuracy that lends confidence to the ability of 
the model to make accurate novel predictions. 
The N. crassa iJDZ836 model also demonstrates high accuracy in predicting the 
ability of different nutrients to rescue essential gene knockouts and in predicting synthetic 
lethal interactions. In the former case, the model displays nearly 90% accuracy on an 
independent test set of nutrient rescue experiments. In the latter case, we were only able 
to curate a handful of experimentally verified synthetic lethal interactions. Nonetheless, 
although no synthetic lethal data was used during model training, the model was able to 
correctly identify four out of five known synthetic lethal interactions.  
Genome-scale metabolic models complement experimental investigations, and 
one role of metabolic modeling is to rapidly generate and prioritize testable predictions 
that can be used to guide subsequent experimentation. As important as the predictions 
themselves, metabolic models also provide potential mechanistic explanations for the 
results. The explanations provide an important check on the overlying predictions. 
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During the validation of models, these explanations ensure that not only are correct 
answers given, they are given for valid underlying reasons. For novel predictions, 
mechanistic explanations can provide potential insight into the results as well as tangible 
avenues to experimental validation. To illustrate the last point, in Text S4 and Figure S5 
we simulate the observed physiological effect of oxygen limitation on ethanol production 
when grown on xylose. Therefore, our model can be used to simulate perturbations that 
optimize ethanol yield, which can then be verified experimentally. 
As with all previous modeling efforts, errors in predicting known experimental 
results highlight limitations in either the model itself or the modeling framework. In 
terms of the model, the quality will only be as good as the information that was used to 
develop it. In the case of Neurospora, the extraordinarily rich literature for this well-
studied model organism was the foundation that enabled a model to be generated that 
performed with high accuracy. Nonetheless, certain areas of the model remain less well 
developed, and one value of model construction is the objective measure it can provide 
on the relative information available for different aspects of metabolism. This can be used 
to target areas that are less well understood. For example, the substrates of certain 
reactions in the thiamin diphosphate and neurosporaxanthin biosynthesis pathways and 
the fate of the end-product in the histidine degradation pathway cannot be included with 
confidence in any metabolic model, because they are open biochemical questions (Karp, 
Paley et al. 2010). 
More generally, the constraint-based modeling framework we used here is known 
to suffer from certain limitations. As with similar models, this accounts for a significant 
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portion of the prediction errors in the Neurospora model. In particular, our model does 
not account for regulation of either enzyme expression or activity. These factors 
sometimes acted in combination. An illustrative example is gln-1 and gln-2, which code 
for the alpha and beta subunit, respectively, of glutamine synthetase (Davila, Brom et al. 
1983). Our model requires both subunits for enzyme catalysis. However, it was 
experimentally shown that concentration of extracellular ammonium regulates this 
enzyme’s subunit composition, which can include both subunits, only alpha subunits, or 
only beta subunits (Mora 1990). This metabolic complexity highlights the need for the 
future incorporation of kinetics and regulation. 
In one instance, however, a prediction initially thought to be an error provided the 
means to identify an issue with an experimentally observed knockout. The viability 
phenotype experiment for Δerg-14 was performed on a knockout strain originally 
designated as a homokaryon. Experimental observations of this strain revealed a normal 
growth phenotype. In contrast, the model predicted that the Δerg-14 mutant was blocked 
in the production of mevalonate, which is a necessary precursor for the sterol component 
of biomass. Moreover, previous efforts to phenotype temperature-sensitive mutants of 
erg-14 revealed severe morphological defects that were expected to be lethal in the full 
knockout (Seiler and Plamann 2003). Driven by these inconsistencies, a re-examination 
of the Δerg-14 knockout revealed that the mutant used was in fact a heterokaryon. This 
prediction, in effect, served as a blind control that highlighted the predictive value of the 
model. 
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The construction of genome-scale metabolic models remains a daunting task. 
Even aided by sophisticated tools for the management and visualization of pathway 
knowledge, a metabolic reconstruction still requires substantial manual review of the 
corresponding literature (Thiele and Palsson 2010). Moreover, it is desirable that the 
model construction process be guided by objective and quantitative measures of 
predictive accuracy. Incorporating this requirement into the model generation process 
increases the complexity of the task by requiring iterative cycles of data curation, model 
improvement, and accuracy assessment. To facilitate the process of model improvement, 
a number of tools have been developed (Reed, Patel et al. 2006; Kumar, Dasika et al. 
2007; Elloumi, Küng et al. 2008; Christian, May et al. 2009; Henry, Zinner et al. 2009; 
Kumar and Maranas 2009; Henry, DeJongh et al. 2010; Jerby, Shlomi et al. 2010; 
Zomorrodi and Maranas 2010; Agren, Bordel et al. 2012; Latendresse, Krummenacker et 
al. 2012). We contribute to this set of tools with the development of a set of optimization-
based algorithms, which together comprise Fast Automated Reconstruction of 
Metabolism (FARM).  
Two of the three FARM algorithms specifically facilitate the process of model 
construction. Consistent Reproduction Of growth/no-growth Phenotype (CROP) assists in 
automating the process of adding and subtracting reactions from a model to improve 
predictive accuracy. CROP integrates diverse evidence for pathways into a probabilistic 
framework that assigns a weight to each reaction associated with the likelihood that the 
reaction is present in the network. These weights are then used to guide the selection of 
reactions to add or remove. Previous methods to achieve in silico growth used mixed 
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integer linear programming (MILP), and thus required substantial compute time (Reed, 
Patel et al. 2006; Kumar and Maranas 2009; Henry, DeJongh et al. 2010). For CROP, we 
utilize LP relaxation, which is faster by orders-of-magnitude. 
OnePrune was developed to efficiently solve the problem of removing reactions 
that are blocked. OnePrune utilizes the goal programming optimization framework to 
achieve multiple competing objectives. The advantage of this framework is that once an 
individual objective is achieved, the optimization can pursue other objectives. OnePrune's 
goals are to send flux through as many reactions as possible, so once a reaction has 
achieved a nonzero flux, OnePrune is free to pursue flux through other reactions. Thus, 
OnePrune identified which reactions could carry flux with a single compact linear 
program. 
The third FARM algorithm, limed-FBA, is an enhancement to the FBA method 
that improves predictive accuracy. limed-FBA accounts for the dilution of active 
metabolites that is ignored by FBA (Figure 34B), so limed-FBA is able to correctly 
identify the essentiality of reactions that are typically missed by standard FBA. For 
example, FBA predicted that pab-1 was not essential, because pab-1 serves as input to a 
metabolic cycle; however, limed-FBA predicted that pab-1 was essential. In fact, 
essentiality of pab-1 was shown by the original experiment of Beadle and Tatum on 
Neurospora crassa (Beadle and Tatum 1941; Tatum and Beadle 1942). 
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Appendices 
 
Figure S 1. The mechanistic explanation for the Δarg-4Δarg-11 synthetic lethal prediction is that two alternate 
routes exist for generating L-ornithine. (A) When arg-4 is blocked, L-ornithine can be generated from arg-
11. (B) When arg-11 is blocked, L-ornithine can be generated via arg-4. 
 
 
Figure S 2. The mechanistic explanation for the ΔsucΔcomplex I synthetic lethal prediction is that two alternate 
routes exist in the mitochondrion for regenerating NAD+ from NADH. (A) The first route utilizes the 
ubiquinone:NADH oxidoreductase enzyme encoded by complex I. (B) When  ubiquinone:NADH 
oxidoreductase activity is blocked, NAD+ still can be regenerated by driving the malate dehydrogenase 
reaction backwards via the pyruvate carboxylase activity encoded by suc. When both routes are blocked, 
the mitochondria unable to regenerate NAD+ from NADH and the resulting double mutant is inviable. 
102 
 
 
 
Figure S 3. Zoomable metabolic map of Neurospora crassa. 
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Figure S 4. Plots glucose uptake rate (in millimoles per gram dry weight per hour) against doubling time (in 
hours).  The black curve depicts the model’s predictions using FBA, where doubling time is calculated as 
ln(2)/growth rate (Ibarra, Edwards et al. 2002), and the blue diamonds depict data points extracted from the 
experimental literature. 
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Figure S 5. Simulating the effect of oxygen limitation on xylose fermentation. In the first step, xylose is reduced 
to xylitol via a xylose reductase that has a strong cofactor preference for for NADPH (XR-NADPH) and a 
weaker preference for NADH (XR-NADH) (Woodyer, Simurdiak et al. 2005). In the second step, xylitol is 
either excreted into the medium or oxidized to xylulose via a NAD+-dependent xylitol dehydrogenase 
(XDH) (Phadtare, Rawat et al. 1997). Xylulose is then phosphorylated and enters the pentose phosphate 
pathway, followed by glycolysis to pyruvate, and is either excreted as ethanol or enters the mitochondria to 
be oxidized via the TCA cycle (Zhang, Qu et al. 2008). (A) Under anaerobic conditions, our model predicts 
that XR-NADH is the only source of NAD+ for XDH, so the excess xylitol generated by XR-NADPH is 
exported, resulting in lower ethanol yields. (B) Under fully aerobic conditions, our model predicts that 
XDH no longer acts as a bottleneck because NAD+ is regenerated by oxygen via the glycerol phosphate 
shuttle. Furthermore, enough oxygen is present to generate the NAD+ required by the TCA cycle, which 
converts all the pyruvate to CO2 and water, resulting in no ethanol production. (C) This figure shows the 
critical oxygen level where just enough NAD+ is regenerated via the glycerol phosphate shuttle to allow 
XDH to catalyze all the xylitol, but there is no NAD+ left over to power the TCA cycle, resulting in 
optimal ethanol yield and productivity. All three predictions of xylitol and ethanol yields are consistent 
with experimental observation (Zhang, Qu et al. 2008).
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